
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59E58D926538F33AE58D00539ECD42.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="frontonco">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9768488/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Frontiers in Oncology">
<meta name="citation_title" content="Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector">
<meta name="citation_author" content="Nerina C van der Merwe">
<meta name="citation_author_institution" content="Division of Human Genetics, National Health Laboratory Service, Universitas Hospital, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Kholiwe S Ntaita">
<meta name="citation_author_institution" content="Division of Human Genetics, National Health Laboratory Service, Universitas Hospital, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Hanri Stofberg">
<meta name="citation_author_institution" content="Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Herkulaas MvE Combrink">
<meta name="citation_author_institution" content="Office of the Dean, Economic and Management Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Interdisciplinary Centre for Digital Futures, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Jaco Oosthuizen">
<meta name="citation_author_institution" content="Division of Human Genetics, National Health Laboratory Service, Universitas Hospital, Bloemfontein, South Africa">
<meta name="citation_author_institution" content="Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa">
<meta name="citation_author" content="Maritha J Kotze">
<meta name="citation_author_institution" content="Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa">
<meta name="citation_author_institution" content="Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa">
<meta name="citation_publication_date" content="2022 Dec 7">
<meta name="citation_volume" content="12">
<meta name="citation_firstpage" content="938561">
<meta name="citation_doi" content="10.3389/fonc.2022.938561">
<meta name="citation_pmid" content="36568162">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9768488/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9768488/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9768488/pdf/fonc-12-938561.pdf">
<meta name="description" content="Translation of genomic knowledge into public health benefits requires the implementation of evidence-based recommendations in clinical practice. In this study, we moved beyond BRCA1/2 susceptibility testing in breast and ovarian cancer patients to ...">
<meta name="og:title" content="Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Translation of genomic knowledge into public health benefits requires the implementation of evidence-based recommendations in clinical practice. In this study, we moved beyond BRCA1/2 susceptibility testing in breast and ovarian cancer patients to ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9768488/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9768488">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3389/fonc.2022.938561"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/fonc-12-938561.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9768488%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9768488/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9768488/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9768488/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-frontonco.gif" alt="Frontiers in Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Frontiers in Oncology" title="Link to Frontiers in Oncology" shape="default" href="http://www.frontiersin.org/oncology" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Front Oncol</button></div>. 2022 Dec 7;12:938561. doi: <a href="https://doi.org/10.3389/fonc.2022.938561" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3389/fonc.2022.938561</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Front%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Front%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Front%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Implementation of multigene panel testing for breast and ovarian cancer in South Africa: A step towards excellence in oncology for the public sector</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20der%20Merwe%20NC%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Nerina C van der Merwe</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Nerina C van der Merwe</span></h3>
<div class="p">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Universitas Hospital, Bloemfontein, South Africa
</div>
<div class="p">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20der%20Merwe%20NC%22%5BAuthor%5D" class="usa-link"><span class="name western">Nerina C van der Merwe</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ntaita%20KS%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Kholiwe S Ntaita</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Kholiwe S Ntaita</span></h3>
<div class="p">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Universitas Hospital, Bloemfontein, South Africa
</div>
<div class="p">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ntaita%20KS%22%5BAuthor%5D" class="usa-link"><span class="name western">Kholiwe S Ntaita</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stofberg%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Hanri Stofberg</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Hanri Stofberg</span></h3>
<div class="p">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stofberg%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hanri Stofberg</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Combrink%20HM%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Herkulaas MvE Combrink</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Herkulaas MvE Combrink</span></h3>
<div class="p">
<sup>3</sup>
Office of the Dean, Economic and Management Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">
<sup>4</sup>
Interdisciplinary Centre for Digital Futures, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Combrink%20HM%22%5BAuthor%5D" class="usa-link"><span class="name western">Herkulaas MvE Combrink</span></a>
</div>
</div>
<sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oosthuizen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jaco Oosthuizen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jaco Oosthuizen</span></h3>
<div class="p">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Universitas Hospital, Bloemfontein, South Africa
</div>
<div class="p">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oosthuizen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jaco Oosthuizen</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kotze%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Maritha J Kotze</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Maritha J Kotze</span></h3>
<div class="p">
<sup>5</sup>
Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa
</div>
<div class="p">
<sup>6</sup>
Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kotze%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Maritha J Kotze</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>†</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Division of Human Genetics, National Health Laboratory Service, Universitas Hospital, Bloemfontein, South Africa
</div>
<div id="aff2">
<sup>2</sup>
Division of Human Genetics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div id="aff3">
<sup>3</sup>
Office of the Dean, Economic and Management Sciences, University of the Free State, Bloemfontein, South Africa
</div>
<div id="aff4">
<sup>4</sup>
Interdisciplinary Centre for Digital Futures, University of the Free State, Bloemfontein, South Africa
</div>
<div id="aff5">
<sup>5</sup>
Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa
</div>
<div id="aff6">
<sup>6</sup>
Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Edited by: Tamrat Abebe Zeleke, Addis Ababa University, Ethiopia</p></div>
<div class="fn" id="fn2"><p>Reviewed by: Steven Narod, University of Toronto, Canada; Deepak Vangala, University Hospital Bochum GmbH, Germany</p></div>
<div class="fn" id="fn001">
<sup>✉</sup><p class="display-inline">*Correspondence: Nerina C. van der Merwe, <span>vanderMerweNC@ufs.ac.za</span>
</p>
</div>
<div class="fn" id="fn003"><p>†These authors share last authorship</p></div>
<div class="fn" id="fn002"><p>This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology</p></div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 May 7; Accepted 2022 Nov 8; Collection date 2022.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2022 van der Merwe, Ntaita, Stofberg, Combrink, Oosthuizen and Kotze</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9768488  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36568162/" class="usa-link">36568162</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Translation of genomic knowledge into public health benefits requires the implementation of evidence-based recommendations in clinical practice. In this study, we moved beyond <em>BRCA1/2</em> susceptibility testing in breast and ovarian cancer patients to explore the application of pharmacogenetics across multiple genes participating in homologous recombination DNA damage repair. This involved the utilisation of next-generation sequencing (NGS) at the intersection of research and service delivery for development of a comprehensive genetic testing platform in South Africa. Lack of international consensus regarding risk categorization of established cancer susceptibility genes and the level of evidence required for prediction of drug response supported the development of a central database to facilitate clinical interpretation. Here we demonstrate the value of this approach using NGS to 1) determine the variant spectrum applicable to targeted therapy and implementation of prevention strategies using the 15-gene Oncomine™ BRCA Expanded Panel, and 2) searched for novel and known pathogenic variants in uninformative cases using whole exome sequencing (WES). Targeted NGS performed as a routine clinical service in 414 South African breast and/or ovarian cancer patients resulted in the detection of 48 actionable variants among 319 (15%) cases. <em>BRCA1/2</em>-associated cancers were identified in 70.8% of patients (34/48, including two double-heterozygotes), with the majority (35.3%, 12/34) representing known South African founder variants. Detection of actionable variants in established non-<em>BRCA1/2</em> risk genes contributed 29% to the total percentage (14/48), distributed amongst <em>ATM</em>, <em>CHEK2</em>, <em>BARD1</em>, <em>BRIP1</em>, <em>PALB2</em> and <em>TP53</em>. Experimental WES using a virtually constructed multi-cancer NGS panel in 16 genetically unresolved cases (and four controls) revealed novel protein truncating variants in the basal cell carcinoma gene <em>PTCH1</em> (c.4187delG) and the signal transmission and transduction gene <em>KIT</em> (c.930delA) involved in crucial cellular processes. Based on these findings, the most cost-effective approach would be to perform <em>BRCA1/2</em> founder variant testing at referral, followed by targeted multigene panel testing if clinically indicated and addition of WES in unresolved cases. This inventive step provides a constant flow of new knowledge into the diagnostic platform <em>via</em> a uniquely South African pathology-supported genetic approach implemented for the first time in this context to integrate research with service delivery.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> multigene panel testing, South Africa, oncology, next-generation sequencing, hereditary breast and ovarian cancer (HBOC) syndrome</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>Breast cancer is the most common cancer affecting women worldwide. An estimated two million new cases will be diagnosed per year. (<a href="#B1" class="usa-link" aria-describedby="B1">1</a>, <a href="#B2" class="usa-link" aria-describedby="B2">2</a>). The incidence is also increasing in South Africa, with an average rate of 1 in 32 for breast cancer development in females (<a href="#B3" class="usa-link" aria-describedby="B3">3</a>). Although most cases occur sporadically, 15–20% are associated with an inherited predisposition characterized by early-onset cancer in affected families (<a href="#B4" class="usa-link" aria-describedby="B4">4</a>). Translating population risk stratification to personal utility relies on evidence-based recommendations informed by the gene variant spectrum that may differ between countries. This is of particular relevance in South Africa due to a complex history of population migration over a period of 300 years, which resulted in varying degrees of founder pathogenic variants as detected in the two major cancer susceptibility genes, <em>BRCA1</em> and <em>BRCA2</em> (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>, <a href="#B6" class="usa-link" aria-describedby="B6">6</a>). These migration events included European colonialism, expansion of Africans to the south, and the introduction of laborers from southern Asia (<a href="https://southafrica-info.com/people/south-africa-population/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://southafrica-info.com/people/south-africa-population/</a>). Collectively, when entwined with indigenous populations already residing at the most southern tip of the African continent, a unique genetic architecture evolved through mutational events and founder effects characteristic of the South African population comprising approximately 61 million people, being neither culturally, linguistically nor genetically homogenous.</p>
<p>Detection of pathogenic variants with varying penetrance in the <em>BRCA1</em> and <em>BRCA2</em> genes are responsible for approximately two-thirds of hereditary breast and ovarian cancer, with cumulative risks ranging from 16–84% and 11–87% for <em>BRCA2</em> and <em>BRCA1</em>, respectively, by age 80 years (<a href="#B7" class="usa-link" aria-describedby="B7">7</a>). The most extensive <em>BRCA1/2</em> series reported to date in the public sector of South Africa (<em>n</em>=1 429) revealed a positivity rate of 9.2% (<em>n</em>=137) actionable variants detected, with the majority (74%, 241 of 326) identified as founder variants (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>). Despite the increase in throughput using next-generation sequencing (NGS) for <em>BRCA1/2</em> variant detection, less than 10% of patients with a personal history of breast and/or ovarian cancer received a positive test result. International studies furthermore indicated that for many genes, the evidence of an association with breast cancer is weak or imprecise, while reliable subtype-specific risk estimates are lacking. This led to large population studies such as those performed by the Breast Cancer Association Consortium (BCAC), which collectively screened more than 60 000 cancer patients and 53 000 control individuals for pathogenic variants in 34 breast cancer susceptibility genes (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>).</p>
<p>Based on the estimated overall risk for breast cancer protein-truncating variants, <em>ATM</em>, <em>BRCA1</em>, <em>BRCA2</em>, <em>CHEK2</em> and <em>PALB2</em> were identified as the major cancer susceptibility genes in the study population (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>). The risk implications of <em>TP53</em> characterized by predominance of causative missense variants, as well as <em>BARD1</em>, <em>RAD51C, RAD51D</em>, <em>PTEN, NF1</em> and <em>MSH6</em>, were defined as modest. Among these 12 genes, <em>ATM</em> and <em>CHEK2</em> had a stronger association with estrogen receptor (ER)–positive than with ER-negative breast cancer. In the case of <em>BARD1, BRCA1</em>, <em>BRCA2, PALB2, RAD51C</em>, and <em>RAD51D</em>, the odds ratios were higher for ER-negative breast cancer than for ER-positive breast cancer. Among the genes that had no evidence of a weak association with breast cancer overall, <em>FANCM</em> showed association with ER-negative breast cancer and <em>FANCC</em> with triple-negative breast cancer. Notably, the risk categorization of <em>ATM</em> changed from a moderate- to a high-risk gene, whereas the gene encoding for the cell-cell adhesion protein E-cadherin (<em>CDH1</em>) lost its place as a high-risk gene when based on the relationship between gene variant and protein expression data presented by the BCAC. Representation of the histopathology and tumour subtypes routinely assessed as therapeutic biomarkers may therefore affect risk classification, as also evidenced by the clinical relevance of pathogenic germline <em>CDH1</em> variants to invasive lobular breast cancer, but not ductal carcinoma of no special type. These findings underscore the potential value of pathology-supported genetic testing as a relatively new concept applied in breast cancer risk stratification with genetic counselling support (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>, <a href="#B10" class="usa-link" aria-describedby="B10">10</a>, <a href="#B11" class="usa-link" aria-describedby="B11">11</a>), to help bridge the clinical interpretation gaps identified in Africa (<a href="https://www.aasciences.africa/publications/policy-paper-framework-implementation-genomic-medicine-public-health-africa" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.aasciences.africa/publications/policy-paper-framework-implementation-genomic-medicine-public-health-africa</a>). Most of the work in cancer genomics are performed in the context of research, but to move from basic research to translation requires feasibility and health economic studies performed in parallel to assay validation.</p>
<p>Evidence provided by consortia such as BCAC resulted in multigene panel screening, which together with whole exome/genome sequencing (WES/WGS), is becoming standard practice internationally. Genome-scale sequencing analysis and data sharing between African counties enable translational research involving return of results to eligible patients (<a href="#B12" class="usa-link" aria-describedby="B12">12</a>). We first reported the value of experimental WES in relation to a previously detected <em>BRCA1</em> variant of uncertain clinical significance (VUS) in a patient with a novel pathogenic <em>PALB2</em> variant, subsequently confirmed by Sanger sequencing (<a href="#B13" class="usa-link" aria-describedby="B13">13</a>). In another South African patient with recurrent breast cancer, WGS supported the discovery of a unique <em>TP53</em> germline variant as the most likely cause of breast and other cancers in the family (<a href="#B14" class="usa-link" aria-describedby="B14">14</a>). These findings justified the establishment of a cancer genomic database and patient registry to optimise the clinical management of individual patients at the intersection of research and service delivery (<a href="https://console.virtualpaper.com/stellenbosch-university/research19/#46/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://console.virtualpaper.com/stellenbosch-university/research19/#46/</a>). Due to high costs and current limited interdisciplinary access to this resource, multigene panel testing was earmarked as a cost-effective diagnostic solution to reduce the cancer burden in South Africa. Lack of international consensus regarding the optimal number of genes to screen based on their clinical relevance and evidence-level for prediction of treatment response in breast and ovarian cancer patients, necessitated the development of a multi-assay platform for application of personalized genomic medicine (<a href="#B15" class="usa-link" aria-describedby="B15">15</a>). The high cumulative genetic risks incurred by pathogenic <em>BRCA1/2</em> variants paved the way for rapid founder variant testing as the first step to increase access to cancer genetic testing in South Africa and to reduce loss to follow-up (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>, <a href="#B16" class="usa-link" aria-describedby="B16">16</a>). The next step towards excellence in surgery and oncology involves multigene panel testing to determine the variant spectrum in additional moderate- to high-risk genes underlying breast and ovarian cancer in South African patients.</p>
<p>Targeted multigene panel testing involves the screening of various established hereditary breast and ovarian cancer genes as described above, simultaneously at costs often reported as lower than testing for <em>BRCA1</em> and <em>BRCA2</em> alone (<a href="#B17" class="usa-link" aria-describedby="B17">17</a>). Implementing such a panel including high- to moderate-risk genes involved in homologous recombination DNA damage repair (<a href="#B18" class="usa-link" aria-describedby="B18">18</a>) could hold great promise to maximize health benefits in a developing country. The potentially benefit lies not only in explaining <em>BRCA-</em>negative inherited breast and ovarian cancer, but also the identification of cancer patients and at-risk family members eligible for clinical interventions, surveillance screening, targeted therapy and potential prevention strategies (<a href="#B19" class="usa-link" aria-describedby="B19">19</a>). We, therefore, evaluated the relevance of the commercially available Oncomine™ BRCA Expanded Panel including 15 genes targeting the homologous recombination DNA damage repair pathway in parallel to WES as a discovery tool. If supported by our data, the integration of research and service delivery will improve the efficiency of breast and ovarian screening in South Africa, while at the same time increase our knowledge of genes involved in homologous recombination repair of double-strand DNA breaks. Together with BRCA1, proteins such as ATM, CHEK2, Tp53, BARD1 and BRIP1 are involved in the recognition of double-strand DNA breaks and the assembly of the repair proteins to the breakpoint (<a href="#B20" class="usa-link" aria-describedby="B20">20</a>–<a href="#B22" class="usa-link" aria-describedby="B22">22</a>). Once at the site, it is the function of the MRN complex to resect the blunt ends of the break and stabilize the break (<a href="#B23" class="usa-link" aria-describedby="B23">23</a>). At this point, with the assistance of PALB2, BRCA2 and RAD51 loading, strand invasion commences to complete the repair process (<a href="#B24" class="usa-link" aria-describedby="B24">24</a>). The question is whether the implementation of multigene panel testing could contribute to and complement the vision of better health systems for Africa across the continuum of cancer care. We believe that bridging the clinical implementation gap between research and service delivery (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>, <a href="#B25" class="usa-link" aria-describedby="B25">25</a>) will advance the knowledge of hereditary breast and ovarian cancer in South Africa as a representative of the African continent. Complementing targeted multigene panel testing with comprehensive genome-scale screening using WES/WGS offers unique learning and capacity-building opportunities. By prioritizing the development of resources needed to integrate research and service delivery, loss of employment opportunities can be prevented, while the scope of clinical research avenues available to African scientists are increased. We envisage a future where our translational research focus will encourage both public and private practicing healthcare practitioners to refer patients for genomic testing at the National Health Laboratory Service in South Africa.</p></section><section id="s2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="s2_1"><h3 class="pmc_sec_title">Study population</h3>
<p>Blood samples of 414 patients attending various genetic clinics across South Africa were received at the National Health Laboratory Service Human Genetics laboratory in Bloemfontein, South Africa. The patients represented individuals diagnosed mostly with either breast or ovarian cancer, who requested diagnostic screening using NGS of genes involved in the development of hereditary breast and ovarian cancer. All the patients underwent pre- and post-test counseling at their respective referring institute, where clinical information together with disclosure of a personal and/or familial aggregation of cancer cases was provided by the referring physician and/or genetic counselor. The request was accompanied by written informed consent for DNA testing and data sharing. Patient details were de-identified for publication purposes. The cohort included mostly patients without a family history of cancer, diagnosed at an early age of onset (&lt;45 years). Once analyzed, 95 patients were excluded from this study due to the absence of consent for data sharing. Race/ethnicity was self-reported and represented all main South African population groups. The data sets for the 15 genes are publicly available (ClinVar submission number SUB11378633 [SCV002504693–SCV002505346]).</p></section><section id="s2_2"><h3 class="pmc_sec_title">Targeted sequencing</h3>
<p>DNA was extracted from peripheral blood using an adaption of a standard salting-out method (<a href="#B26" class="usa-link" aria-describedby="B26">26</a>). Germline DNA samples were screened using the NGS Oncomine™ BRCA Expanded Research Assay (Life Technologies, Carlsbad, CA, USA). The primer pools targeted the entire coding region and splice-site junctions. Multiplexed primer pools were used to construct the amplicon library using PCR-based targeted amplification, where after it was sequenced using the Ion GeneStudio™ S5 system (Life Technologies, Carlsbad, CA, USA). Raw signal data were analyzed using the Torrent Suite™ version 5.12.1 (Thermo Fisher Scientific Inc., Waltham, MA, USA). The pipeline included signaling processing, base calling, quality score assignment, trimming of the adapters (average read length 121 bps), read alignment, and quality control of mapping quality. The Ion Reporter™ Software version 5.18.2 (Thermo Fisher Scientific Inc., Waltham, MA, USA) was used for filtering out possible artifacts and the annotation of variants. Coverage analysis and variant calling were generated using the Torrent Variant Caller plugin software in the Torrent Server. The average coverage depths obtained were 936X (range 745–1164X).</p>
<p>Using the depth per read, quartile statistics was applied to calculate the average depth distribution around the mean across the samples. Samples that were located within the 2nd and 3rd quartile, were selected to construct a copy number variant baseline with the Ion Reporter CNV VCIB 4.0.0.1 algorithm. Copy number variant detection for the 15 genes was performed using an algorithm that normalized depth coverage across amplicons to predict the copy number or ploidy states. The computed baseline included a minimum of 100 control samples (each with an average of 70–140 million bases called greater than Q20 and a read count of 0.6–1.2 million), using regions with known ploidy states (<a href="https://assets.thermofisher.com/TFS-Assets/LSG/brochures/CNV-Detection-by-Ion.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://assets.thermofisher.com/TFS-Assets/LSG/brochures/CNV-Detection-by-Ion.pdf</a>).</p></section><section id="s2_3"><h3 class="pmc_sec_title">Multiplex ligation-dependent probe amplification</h3>
<p>Multiplex ligation-dependent probe amplification was used to confirm copy number variants situated in genes for which pre-designed assays were readily available (MRC-Holland, Amsterdam, The Netherlands). These assays covered the complete coding regions for both <em>BRCA1</em> and <em>BRCA2</em>, whereas the design focused on well-established copy number variant regions or hot spots for <em>TP53</em>, <em>ATM</em>, <em>FANCD2</em>, <em>PALB2</em>, <em>CHEK2</em>, <em>BRIP1</em>, <em>BARD1</em>, and <em>NBN</em>. For less familiar genes, copy number variants detected using NGS were investigated and confirmed by comparing results for duplicated samples in separate runs in the presence of a positive copy number variant control (a quality indicator for library preparation). The ligated products were run together with a size standard on an ABI 3500XL Genetic analyzer (Applied Biosystems, Carlsbad, California, USA). Multiplex-ligation-dependent probe amplification data were analyzed using GeneMarker® software version 3.0.1 (SoftGenetics, LCC, State College, PA, USA). Confirmed copy number variants were named according to the Human Genome Variation Society (<a href="http://www.HGVS.org/varnomen" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.HGVS.org/varnomen</a>) guidelines and classified using the adapted recommendations of the American Society of Medical Genetics and Genomics for the interpretation and reporting of a single-gene copy number variant (<a href="#B27" class="usa-link" aria-describedby="B27">27</a>). On occasion and depending on quality parameters, potential likely pathogenic and pathogenic variants (especially single nucleotide variants in homopolymer regions) were confirmed using Sanger DNA sequencing. Sanger sequencing was performed using the ABI Prism BigDye<sup>®</sup> Terminator v3.1 cycle sequencing kit (Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s protocols.</p></section><section id="s2_4"><h3 class="pmc_sec_title">Whole exome sequencing</h3>
<p>Exploratory WES was performed for a limited number of <em>BRCA</em>-negative patients (<em>n</em>=16) and control samples of known genotype (n=4) to assist with the validation process of the BRCA Expanded 15-gene panel. Comparison of the data produced using the two technologies provided insight regarding the cost-benefit of WES for variant and gene discovery based on a virtual panel of 84 cancer-related genes. Simultaneously, potential analytical challenges were highlighted regarding optimal depth needed for accurate variant calling through coverage and variant spectrum. WES was performed according to the methods previously described as part of postgraduate training (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>, <a href="#B28" class="usa-link" aria-describedby="B28">28</a>). Genomic quality scores were determined on the LabChip<sup>®</sup> GXII Touch (PerkinElmer, Waltham, MA, USA), using the DNA Extended Range Chip and genomic DNA Reagent Kit (PerkinElmer). The Ion AmpliSeq™ Exome RDY Kit was used to prepare exome libraries, where after these targets were amplified using the Ion AmpliSeq™ Exome RDY Panel and the Ion AmpliSeq Library Kit Plus. The products were combined, and primer sequences digested to generate barcoded libraries after purification with Agencourt™ AMPure XP magnetic beads. The barcoded exome libraries were combined for sequencing template preparation using the Ion 540 Chef Kit, where after the pooled library was loaded onto the Ion Chef for template preparation and enrichment using Ion 540 Chef Reagents. Sequencing was performed on the Ion Torrent Ion S5 platform and the Ion Reporter software used for variant calling (<a href="#B28" class="usa-link" aria-describedby="B28">28</a>) of high to moderate-risk cancer genes using the Invitae multi-cancer panel (<a href="#SM1" class="usa-link">
<strong>Table S1</strong>
</a>, <a href="https://www.ncbi.nlm.nih.gov/gtr/tests/528909/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/gtr/tests/528909/</a>).</p></section><section id="s2_5"><h3 class="pmc_sec_title">Variant classification</h3>
<p>The clinical significance of single nucleotide variants was determined based on the framework of guidelines proposed by the American Society of Medical Genetics and Genomics and the Association for Molecular Pathology (<a href="#B29" class="usa-link" aria-describedby="B29">29</a>), including the amended versions designed specifically for <em>TP53</em> (<a href="#B30" class="usa-link" aria-describedby="B30">30</a>) and <em>ATM</em> (<a href="#B31" class="usa-link" aria-describedby="B31">31</a>). These guidelines together with freely accessible public databases such as ClinVar, LOVD, BRCA Exchange, and the genomic search engine VarSome (<a href="#B32" class="usa-link" aria-describedby="B32">32</a>) were used for ultimate variant classification. The mutation nomenclature was used according to Human Genome Variation Society recommendations. The genes analyzed were numbered and annotated using the National Center for Biotechnology Information chromosome and transcript reference sequences, as listed in <a href="#T1" class="usa-link">
<strong>Tables 1</strong>
</a>, <a href="#SM1" class="usa-link">
<strong>S1</strong>
</a>. Variants detected were categorized according to the Evidence-based Network for the Interpretation of Germline Mutant Alleles consortium.</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Summary of variants detected during comprehensive screening of 319 patients using the Oncomine™ BRCA Expanded panel.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="top" align="left" rowspan="1" colspan="1">Gene</th>
<th valign="top" align="center" rowspan="1" colspan="1">Transcript</th>
<th valign="top" align="center" rowspan="1" colspan="1">mRNA length</th>
<th valign="top" align="center" rowspan="1" colspan="1">Total <em>n</em> of variants</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>n</em> and (%) of novel variants</th>
<th valign="top" align="center" rowspan="1" colspan="1">% of intronic variants</th>
<th valign="top" align="center" rowspan="1" colspan="1">% of coding variants</th>
<th valign="top" align="center" rowspan="1" colspan="1">% of missense variants</th>
<th valign="top" align="center" rowspan="1" colspan="1">% of synonymous variant</th>
<th valign="top" align="center" rowspan="1" colspan="1">% of stop-gain variants</th>
<th valign="top" align="center" rowspan="1" colspan="1">% of in- frame deletions</th>
<th valign="top" align="center" rowspan="1" colspan="1">% of frameshift variants</th>
<th valign="top" align="center" rowspan="1" colspan="1">
<em>n</em> and (%) of actionable variants</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>ATM*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 000051.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">12,915 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">155</td>
<td valign="top" align="center" rowspan="1" colspan="1">16 (10.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">48</td>
<td valign="top" align="center" rowspan="1" colspan="1">52</td>
<td valign="top" align="center" rowspan="1" colspan="1">69</td>
<td valign="top" align="center" rowspan="1" colspan="1">26</td>
<td valign="top" align="center" rowspan="1" colspan="1">I</td>
<td valign="top" align="center" rowspan="1" colspan="1">I</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 <em>(</em> 1.3)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BARD*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 000465.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">5,478 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">55</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (5.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">38</td>
<td valign="top" align="center" rowspan="1" colspan="1">62</td>
<td valign="top" align="center" rowspan="1" colspan="1">73</td>
<td valign="top" align="center" rowspan="1" colspan="1">17</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (3.6)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA1*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 007294.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">7,088 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">80</td>
<td valign="top" align="center" rowspan="1" colspan="1">9 (11.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">27</td>
<td valign="top" align="center" rowspan="1" colspan="1">73</td>
<td valign="top" align="center" rowspan="1" colspan="1">59</td>
<td valign="top" align="center" rowspan="1" colspan="1">25</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="center" rowspan="1" colspan="1">9</td>
<td valign="top" align="center" rowspan="1" colspan="1">11 (13.8)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRCA2*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 000059.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 1,954 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">120</td>
<td valign="top" align="center" rowspan="1" colspan="1">9 (7.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">22</td>
<td valign="top" align="center" rowspan="1" colspan="1">78</td>
<td valign="top" align="center" rowspan="1" colspan="1">55</td>
<td valign="top" align="center" rowspan="1" colspan="1">29</td>
<td valign="top" align="center" rowspan="1" colspan="1">6</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">7</td>
<td valign="top" align="center" rowspan="1" colspan="1">20 (16.7)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>BRIP1*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 032043.3</td>
<td valign="top" align="center" rowspan="1" colspan="1">8,182 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">39</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (10.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">64</td>
<td valign="top" align="center" rowspan="1" colspan="1">36</td>
<td valign="top" align="center" rowspan="1" colspan="1">71</td>
<td valign="top" align="center" rowspan="1" colspan="1">29</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (5. 1)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>CDK12</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 016507.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">8,287 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">31</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (9.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">39</td>
<td valign="top" align="center" rowspan="1" colspan="1">61</td>
<td valign="top" align="center" rowspan="1" colspan="1">44</td>
<td valign="top" align="center" rowspan="1" colspan="1">56</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>CHEK2*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 007194.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,844 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">20</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (5.0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">43</td>
<td valign="top" align="center" rowspan="1" colspan="1">57</td>
<td valign="top" align="center" rowspan="1" colspan="1">40</td>
<td valign="top" align="center" rowspan="1" colspan="1">40</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">10</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (20.0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>FANCD2</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 033084.6</td>
<td valign="top" align="center" rowspan="1" colspan="1">4,879 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">74</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (9.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">55</td>
<td valign="top" align="center" rowspan="1" colspan="1">45</td>
<td valign="top" align="center" rowspan="1" colspan="1">39</td>
<td valign="top" align="center" rowspan="1" colspan="1">61</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">I (1.4)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>PALB2*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 024675.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">4,008 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">37</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (10.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">53</td>
<td valign="top" align="center" rowspan="1" colspan="1">47</td>
<td valign="top" align="center" rowspan="1" colspan="1">71</td>
<td valign="top" align="center" rowspan="1" colspan="1">24</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">6</td>
<td valign="top" align="center" rowspan="1" colspan="1">I (2.7)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>PPP2R2A</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 002717.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">3,923 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">16</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (6.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">71</td>
<td valign="top" align="center" rowspan="1" colspan="1">29</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">100</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>MRE11</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 005591.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">6,841 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">35</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (8.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">56</td>
<td valign="top" align="center" rowspan="1" colspan="1">44</td>
<td valign="top" align="center" rowspan="1" colspan="1">69</td>
<td valign="top" align="center" rowspan="1" colspan="1">31</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>NBN*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 002485.5</td>
<td valign="top" align="center" rowspan="1" colspan="1">4,622 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">45</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (6.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">54</td>
<td valign="top" align="center" rowspan="1" colspan="1">46</td>
<td valign="top" align="center" rowspan="1" colspan="1">59</td>
<td valign="top" align="center" rowspan="1" colspan="1">41</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RAD51B</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 001321818.2</td>
<td valign="top" align="center" rowspan="1" colspan="1">1,273 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">33</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (9.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">61</td>
<td valign="top" align="center" rowspan="1" colspan="1">39</td>
<td valign="top" align="center" rowspan="1" colspan="1">67</td>
<td valign="top" align="center" rowspan="1" colspan="1">33</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>RAD54L</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 003579.4</td>
<td valign="top" align="center" rowspan="1" colspan="1">3,078 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">35</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (5.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">40</td>
<td valign="top" align="center" rowspan="1" colspan="1">60</td>
<td valign="top" align="center" rowspan="1" colspan="1">58</td>
<td valign="top" align="center" rowspan="1" colspan="1">37</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">5</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>TP53*</em>
</td>
<td valign="top" align="left" rowspan="1" colspan="1">NM 000546.6</td>
<td valign="top" align="center" rowspan="1" colspan="1">2,512 nt</td>
<td valign="top" align="center" rowspan="1" colspan="1">29</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (6.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">65</td>
<td valign="top" align="center" rowspan="1" colspan="1">35</td>
<td valign="top" align="center" rowspan="1" colspan="1">44</td>
<td valign="top" align="center" rowspan="1" colspan="1">44</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">0</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 1</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (3.5)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>Total</em>
</td>
<td valign="top" align="center" rowspan="1" colspan="1"> </td>
<td valign="top" align="left" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1">804</td>
<td valign="top" align="center" rowspan="1" colspan="1">70 (8.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">45</td>
<td valign="top" align="center" rowspan="1" colspan="1">55</td>
<td valign="top" align="center" rowspan="1" colspan="1">59</td>
<td valign="top" align="center" rowspan="1" colspan="1">33</td>
<td valign="top" align="center" rowspan="1" colspan="1">3</td>
<td valign="top" align="center" rowspan="1" colspan="1">2</td>
<td valign="top" align="center" rowspan="1" colspan="1">4</td>
<td valign="top" align="center" rowspan="1" colspan="1">46 (5.7)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fnT2_1">
<p>
<em>n</em>, number; *genes included in the latest National Comprehensive Cancer Network (NCCN guidelines, version 2.2022).</p>
<p>Variants observed in the untranslated regions, together with splice-site variants are included as intronic variants.</p>
</div></div></section></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<p>NGS was used to determine the presence and frequency of likely- to pathogenic variants in genes responsible for hereditary breast and ovarian cancer syndrome in South Africa. The 15-gene panel was designed as a successor to the Oncomine™ BRCA Research Assay (Life Technologies, Carlsbad, CA, USA) (<a href="#B33" class="usa-link" aria-describedby="B33">33</a>) (<a href="#T1" class="usa-link">
<strong>Table 1</strong>
</a>) previously used in a subset of our study population to identify defects in genes involved in the homologous recombination DNA damage repair pathway, which affect response to DNA-damaging therapies (<a href="#B34" class="usa-link" aria-describedby="B34">34</a>, <a href="#B35" class="usa-link" aria-describedby="B35">35</a>). While patients with pathogenic variants in any of the 15 genes included in the NGS panel can be expected to benefit from poly (ADP-ribose) inhibitor treatment, this therapy is not available in the public sector and our findings served to identify a need for targeted therapy as validation of the assay would also have clinical implications for at-risk family members in the broader community. The validation of the expanded panel was simplified as the two assays shared identical primer pools for <em>BRCA1</em> and <em>BRCA2</em>. Using the existing <em>BRCA1/2</em> variant data [compiled from the two-gene <em>BRCA1/2</em> assay (<em>n</em>=1 089), together with the research-based WES results (<em>n</em>=20)], a total of 344 <em>BRCA1/2</em> variants representing both single- and copy number variants were available for cross-correlation (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>).</p>
<p>Our aim was to assess the overall prevalence of potentially relevant cancer risk gene variants in the samples received between June 2021 and February 2022 (<em>n=</em>414 patients), using multigene panel testing. For the section of the cohort with clinical data and consent for data sharing (<em>n</em>=319), a total of 48 actionable variants were identified (<a href="#T2" class="usa-link">
<strong>Table 2</strong>
</a>). <em>BRCA1</em> and <em>BRCA2</em> contributed the most to the pool of likely- to pathogenic variants recorded (<em>n</em>=34/48, 69.4%) (<a href="#T2" class="usa-link">
<strong>Table 2</strong>
</a>), with the majority observed for <em>BRCA2</em> (<em>n=</em>32/48, 66.7%). Five of the six South African specific founder variants were detected, two in <em>BRCA1</em> (<em>n</em>=2/48; c.1374delC, p.Asp458GlufsTer17 and c.2641G&gt;T,p.Glu881Ter) and three in <em>BRCA2</em> (<em>n</em>=10/48; c.582G&gt;A,p.Trp194Ter; c.5771_5774delTTCA, p.Ile1924ArgfsTer38 and c.7934del, p.Arg2654AsnfsTer3) (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>) (<a href="#B5" class="usa-link" aria-describedby="B5">5</a>, <a href="#B6" class="usa-link" aria-describedby="B6">6</a>, <a href="#B8" class="usa-link" aria-describedby="B8">8</a>, <a href="#B36" class="usa-link" aria-describedby="B36">36</a>, <a href="#B37" class="usa-link" aria-describedby="B37">37</a>). The expanded panel detected 10 and 12 non-founder pathogenic variants in <em>BRCA1</em> and <em>BRCA2</em>, respectively, together with three <em>BRCA1</em> copy number variants all representing single exon deletions, confirmed using multiplex ligation-dependent probe amplification (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>). The search revealed three novel variants, two in <em>BRCA1</em> with a single in <em>BRCA2</em> (<em>BRCA1</em> c.302_303delATinsGA, <em>BRCA1</em> c.125dup and <em>BRCA2</em> c.1705C&gt;T, p.Gln569Ter) (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>
<strong>)</strong>. <em>BRCA1</em> c.302_303delATinsGA represented a new splice-site variant, with <em>BRCA1</em> c.125dup (situated in the critical zinc finger domain), postulated to negatively influence the binding between BRCA1 and BARD1. As three separate null variants at the same position as <em>BRCA2</em> c.1705C&gt;T, p.Gln569Ter were previously reported as pathogenic by an expert panel in ClinVar (c.1705del, p.Gln569ArgfsTer4, c.1705insG, p.Gln569AlafsTer21 and c.1705_1706del, p.Gln569GlufsTer20), the variant was classified as likely pathogenic based on the same criteria. Most of the variants were patient-specific (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>).</p>
<section class="tw xbox font-sm" id="T2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Testing results by gene category and personal characteristics.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left" rowspan="1" colspan="1"></th>
<th valign="top" align="center" rowspan="1" colspan="1"></th>
<th valign="top" colspan="3" align="center" rowspan="1">Results by gene category, number (%) of LP and PVs</th>
</tr>
<tr>
<th valign="top" align="left" rowspan="1" colspan="1"></th>
<th valign="top" align="center" rowspan="1" colspan="1">Actionable cases by test result, number (%)</th>
<th valign="top" align="center" rowspan="1" colspan="1">High-risk <em>BRCA1</em> &amp; <em>BRCA2</em>
</th>
<th valign="top" align="center" rowspan="1" colspan="1">Non-<em>BRCA</em> high-risk BC and/or OVC genes</th>
<th valign="top" align="center" rowspan="1" colspan="1">Moderate to lower risk BC and/or OVC genes</th>
</tr>
</thead>
<tbody>
<tr><td valign="top" colspan="5" align="left" rowspan="1">
<strong>Characteristic</strong>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">
<em>Type of cancer diagnosed at any age</em>
</td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
<td valign="top" align="center" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC (<em>n=</em>287)</td>
<td valign="top" align="center" rowspan="1" colspan="1">41* (13.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">27 (9.4)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (0.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12 (4.2)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">OVC (<em>n=</em>3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (33.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (33.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">BC &amp; another ca (<em>n=</em>15)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (20.0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (13.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (6.6)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Prostate ca (<em>n=</em>9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (11.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (11.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Other ca types (<em>n=</em>5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (20.0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (20.0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr><td valign="top" colspan="5" align="left" rowspan="1">
<em>Gender</em>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Female (<em>n=</em>298)</td>
<td valign="top" align="center" rowspan="1" colspan="1">44* (14.1)</td>
<td valign="top" align="center" rowspan="1" colspan="1">30 (10.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (0.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">12 (4.0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Male (<em>n=</em>21)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (14.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (9.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (4.8)</td>
</tr>
<tr><td valign="top" colspan="5" align="left" rowspan="1">
<em>Ethnicity</em>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">African (<em>n=</em>188)</td>
<td valign="top" align="center" rowspan="1" colspan="1">27 (14.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">18 (9.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (0.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (3.7)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Caucasian (<em>n=</em>36)</td>
<td valign="top" align="center" rowspan="1" colspan="1">10 (27.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (13.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">4 (11.1)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Mixed ancestry (<em>n=</em>51)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (13.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">6 (11.8)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (1.9)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Asian (<em>n=</em>32)</td>
<td valign="top" align="center" rowspan="1" colspan="1">5 (15.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">3 (9.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">2 (6.2)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Non-SA (<em>n=</em>12)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr><td valign="top" colspan="5" align="left" rowspan="1">
<em>Age at onset</em>
</td></tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Diagnosis &lt; 45 years (<em>n=</em>168)</td>
<td valign="top" align="center" rowspan="1" colspan="1">26 (15.5)</td>
<td valign="top" align="center" rowspan="1" colspan="1">18 (10.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (0.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (4.2)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Diagnosis ≥ 45 years (<em>n=</em>151)</td>
<td valign="top" align="center" rowspan="1" colspan="1">23 (15.2)</td>
<td valign="top" align="center" rowspan="1" colspan="1">16 (10.6)</td>
<td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">7 (4.6)</td>
</tr>
<tr>
<td valign="top" align="left" rowspan="1" colspan="1">Total (<em>n=</em>319)</td>
<td valign="top" align="center" rowspan="1" colspan="1">49* (14.7)</td>
<td valign="top" align="center" rowspan="1" colspan="1">34* (10.0)</td>
<td valign="top" align="center" rowspan="1" colspan="1">1 (0.3)</td>
<td valign="top" align="center" rowspan="1" colspan="1">14 (4.3)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn6"><p>BC, breast cancer; OVC, ovarian cancer; ca, cancer; LP, likely pathogenic; PV, pathogenic variant; SA, South African; <strong>*</strong>two female BC patients were double heterozygotes with PVs in both <em>BRCA1</em> and <em>BRCA2</em>. Percentages are calculated as the total actionable cases per characteristic.</p></div></div></section><p>Apart from <em>BRCA1</em> and <em>BRCA2, ATM</em> (<em>n</em>=4/48), <em>CHEK2</em> (<em>n</em>=3/48) and <em>BARD1</em> (<em>n</em>=2/48) contributed the most to the positive variant detection rate, with single variants observed for <em>BRIP1</em>, <em>PALB2</em> and <em>TP53</em> (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>). The majority represented single nucleotide variants, with only a single copy number variant identified for <em>ATM</em> (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a> and <a href="#SF1" class="usa-link">
<strong>Figure S1</strong>
</a>). <em>ATM</em> was the largest non-<em>BRCA</em> gene contributing to the increased mutation positivity rate (8.3%, 4/48), followed by <em>CHEK2</em> (3/48). All the variants observed for these two genes were detected in African patients. One of the variants, <em>CHEK2</em> c.283C&gt;T, p.Arg95Ter (rs587781269), represented a recurrent variant observed in two patients, together with a single occurrence reported in an earlier South African study (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>) (<a href="#B38" class="usa-link" aria-describedby="B38">38</a>). Functional assays confirmed the protein to be non-functional in terms of kinase activity and dimerization (<a href="#B39" class="usa-link" aria-describedby="B39">39</a>). A multicentre association study involving more than 113 000 women associated truncating variants in <em>CHEK2</em> with an increase in breast cancer risk [odds ratio of 2.13 (1.60–2.84)] furthermore influenced by the ER status of the tumor [ER+ tumors 2.67 (95% CI, 2.3–3.11)] (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>). This accounted in part for the early age of breast cancer diagnosis in a young male diagnosed with an ER-positive tumor. Although preliminary, this variant could represent the first non-<em>BRCA</em> recurrent pathogenic variant observed in the South African population.</p>
<p>The remainder of variants was observed for <em>PALB2</em>, <em>TP53</em>, <em>BARD1</em>, and <em>BRIP1</em>, with a single likely- to pathogenic variant observed for all genes except <em>BARD1</em> (<em>n</em>=2) (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>). The <em>PALB2</em> c.3507_3508del, p.His1170PhefsTer19 variant resulted in the extension of the WD40 domain that plays a crucial role in the function and stability of the protein during its interaction with BRCA2 (<a href="#B40" class="usa-link" aria-describedby="B40">40</a>). The complex rearrangement observed for <em>TP53</em> (c.158_163delGGTTCAinsAT, p.Trp53SerfsTer69) impacted various critical domains of the protein including the interaction with CCAR2 and HRMT1L2 (<a href="#B41" class="usa-link" aria-describedby="B41">41</a>). As the p53 protein is considered the guardian of the genome, this null variant located in such a hotspot area is associated with a predisposition to cancer in individuals with Li-Fraumeni syndrome (<a href="#B42" class="usa-link" aria-describedby="B42">42</a>). A complete list of the VUSes detected is presented in <a href="#SM3" class="usa-link">
<strong>Table S3</strong>
</a>.</p>
<p>In total, 804 filtered variants were observed distributed amongst the various genes, with 51.5% (414/804) occurring in the coding regions (<a href="#T1" class="usa-link">
<strong>Table 1</strong>
</a>). The bulk of these variants were heterozygous missense variants (59%). Four of the genes had a novel variant percentage above 10% (<em>ATM</em>, <em>BRCA1</em>, <em>BRIP1</em>, and <em>PALB2</em> (32/53)) situated in a domain or important region. <em>BRCA1</em> and <em>BRCA2</em> contributed the most nonsynonymous and frameshift variants to the mutation-positive variant pool. Grouping variants based on clinical significance resulted in 46% (370/804) classified as benign; 41% (330/804) as likely benign; 9% (73/804) as a VUS; 0.1% (1/804) as likely pathogenic and 5.7% as (46/804) pathogenic (<a href="#T1" class="usa-link">
<strong>Table 1</strong>
</a>). The initial VUS percentage was higher, largely due to the inclusion of intronic variants located further than 25 bases from the splice site. These were ultimately reclassified as likely benign based on predicted consequences (<a href="#SM3" class="usa-link">
<strong>Table S3</strong>
</a>
<strong>)</strong>.</p>
<p>The majority of patients were African (<em>n</em>=197, 61.8%), with the remaining 38.2% of the cohort comprising of Asian (<em>n</em>=32, 10.0%, all South African Indian), Caucasian (<em>n</em>=36, 11.3%, mostly Afrikaner) and the Mixed ancestry population (<em>n</em>=51, 16.0%) (<a href="#T2" class="usa-link">
<strong>Table 2</strong>
</a>). Ethnicity was not indicated for three patients. The mean age of diagnosis was 44.8 years, with most presenting with breast cancer (<em>n</em>=302, 94.7%). The additional cancer types included ovarian, cervical, womb, thyroid, prostate, rectal, pancreatic, colon and skin cancer (<em>n</em>=31, 9.7%). A significant number of patients (<em>n</em>=166, 52.0%) reported a family history of cancer, although in most cases represented by only a single affected family member. The presence of a family history was omitted for 42 patients and included patients that were adopted as a child (13.1%). Most of the patients presented with stage II breast cancer (<em>n</em>=96, 30.1%) (<a href="#SM3" class="usa-link">
<strong>Table S3</strong>
</a>).</p>
<p>Twenty patients were selected for WES based on their tumour type and family history of breast/ovarian cancer, including four controls of known genotype replicated in this study. Actionable pathogenic variants were detected in four of the 16 genetically uncharacterized cases, including a pathogenic <em>CHEK2</em> c.283C&gt;T p.Arg95Ter terminating variant in two patients (<a href="#SM2" class="usa-link">
<strong>Table S2</strong>
</a>). Truncating variants were also detected in two lesser-known cancer susceptibility genes, namely <em>PTCH1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000264.5" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000264.5</a>):c.4187delG, p.Gly1396AspfsTer56 and <em>KIT</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000222.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000222.3</a>):c.930delA, p.Gly311AspfsTer8. Since WES was performed in a research environment, DNA samples of the two patients with <em>CHEK2</em> c.283C&gt;T p.Arg95Ter were re-tested using the multigene <em>BRCA</em> expanded panel to confirm the result. This enabled the translation of research findings into clinical practice <em>via</em> the respective referring doctors and patients with genetic counselling support, as illustrated in <a href="#f1" class="usa-link">
<strong>Figure 1</strong>
</a>. Except for a <em>PALB2</em> variant with conflicting evidence of pathogenicity (data not shown) investigated further, WES analysis using a virtual panel of 84 cancer-related genes did not reveal any actionable mutations in the 12 unresolved breast cancer patients.</p>
<figure class="fig xbox font-sm" id="f1"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9768488_fonc-12-938561-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10db/9768488/f1be5e24a91f/fonc-12-938561-g001.jpg" loading="lazy" height="452" width="661" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/f1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flow diagram illustrating integrating research into diagnostic service <em>via</em> a pathology-supported genetic testing platform, developed as a cost saving strategy in South Africa (Adapted with permission from Baatjes et al. [<a href="#B43" class="usa-link" aria-describedby="B43">43</a>)].</p></figcaption></figure></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>In this study we combined targeted and exploratory NGS technologies to develop a comprehensive research-driven genetic testing service for breast and ovarian cancer. This approach has unlimited potential regarding the number of genes accessible for application of personalized genomic medicine. In contrast to targeted NGS, WES is not restricted by the number of genes that can be analysed and this benefit was evident from detection of two novel variants (<em>PTCH1</em> c.4187delG and <em>KIT</em> c.930delA) in genes not included in the 15-gene Oncomine™ BRCA Expanded Panel. WES includes all the coding regions of the human genome containing approximately 85% of clinically relevant gene variants, but data coverage is not uniform. Therefore, virtual NGS panels applied to WES data WES data in a research environment is ideally suited to support continuous updating of the risk categories being allocated to cancer susceptibility genes and overlapping or distinct pharmacogenetic markers. All the patients with likely- to pathogenic variants detected with the 15-gene panel are eligible for targeted therapy and implementation of prevention strategies. By knowing the risks, affected patients and their at-risk family members who may benefit from clinical interventions can be identified and referred to clinicians for implementation of appropriate treatment strategies. <em>BRCA1</em> and <em>BRCA2</em> contributed the most toward the percentage of actionable variants identified, with the majority representing <em>BRCA2</em>. Apart from the founder <em>BRCA1/2</em> variants contributing 35.3% [12/34] to the positivity rate, the 15-gene panel revealed seven variants identified for the first time in South Africa, despite more than 1 400 patients comprehensively screened thus far in our laboratory. This finding illustrates the unique genetic architecture of the South African population and highlights the underrepresentation of African variants in international databases. Moreover, with the necessary approvals being applied for as part of postgraduate studies, we may in future extend the number of overlapping NGS data sets stored in the existing cancer genomics database generated though parallel testing of the 15-gene panel and WES/WGS.</p>
<p>Comparison of our results with those reported by the BCAC highlighted the effectiveness of established selection criteria for familial genetic risk screening, as the average age at onset ranged between 40–55 years of age, similar to our patients (72% diagnosed before age 50 years) (<a href="#B9" class="usa-link" aria-describedby="B9">9</a>) (<a href="#SM1" class="usa-link">
<strong>Supplementary Data</strong>
</a>). Appropriate selection of patients for genetic investigations was reflected by the expected genes and variant types in which pathogenic variants were identified. Should lower-risk patients diagnosed at a later age be representative of most cases in the cohort, a potentially different spectrum of genes and pathogenic variants might be observed. Currently, the lesser-known genes included in the 15-gene panel lack odd ratios and are problematic for quantifying cumulative risk without an appropriate control cohort based on healthy older women. Our data reflect the progress made in South African policies relating to patient selection criteria for the identification of high penetrant variants. At the same time, it also accentuates the inequalities that remain regarding genetic testing of the broader population. This limits our understanding of the healthy human genome and remaining hurdles to overcome for patients to truly benefit from genetic testing. Since research translation requires a seamless process from sample collection to report generation, the development of clinical decision support materials as an integral part of implementation studies is important. Towards this goal, we summarised the current lifetime or absolute risk estimates for genes containing clinically relevant variants in the South African study cohort, as shown in Supplementary <a href="#SM4" class="usa-link">
<strong>Table S4</strong>
</a>. The clinical guidelines indicating the risks and odds ratios for each of the genes, as well as proposed management and potential therapeutic options for mutation carriers, were based on current literature and NCCN Guidelines considered useful for inclusion in patient reports in future.</p>
<p>Genetic testing strategies currently available in the public sector of South Africa do not routinely include WES/WGS or use of genome wide genotyping arrays. While advances in NGS technologies have quickly highlighted WES/WGS as the ultimate discovery tool to gain insight into an individual’s genetic code (<a href="#B44" class="usa-link" aria-describedby="B44">44</a>), it remains costly. Therefore, we use WES/WGS in skills development programs to ultimately curb an increasing trend among healthcare practitioners to refer patient samples abroad through outsourcing. WES-related research is not only an attempt to build and expand the diagnostic service in-house for South African patients, but also to ensure that diagnostic and research material/data remain in the country as far as possible. The safekeeping of valuable data forms the basis for teaching and training of the next generation of South African medical practitioners, including medical scientists and genetic specialists. Storage of genetic information together with phenotypical observations unique to the local population and individual patients, will over time enable retrospective genotype-phenotype association and follow-up studies. This pathology-supported genetic testing approach accelerates data collection and has the potential to reduce the anxiety for patients and their families relating to the odyssey of health research investigations that end up in VUSes or variants discovered in genes with insufficient clinical evidence to act on. This was clearly demonstrated by Moremi et al. (<a href="#B11" class="usa-link" aria-describedby="B11">11</a>), with return of research results to family members of deceased breast cancer patients with somatic <em>TP53</em> variants. Germline WES of stored DNA samples excluded the risk of Li-Fraumeni syndrome for the patients’ family members. As the Department of Health is currently not in a position to offer WES/WGS to patients in the diagnostic laboratory, our data-sharing platform is accessible across participating healthcare institutions to assist with investigations in selected patients. <a href="#f1" class="usa-link">
<strong>Figure 1</strong>
</a> illustrates this process, which was first described by Baatjes et al. (<a href="#B43" class="usa-link" aria-describedby="B43">43</a>) as a further inventive step to identify pathogenic variants that were previously missed, again highlighting the need for universal <em>BRCA1/2</em> screening supported by the unique genetic structure of the South African population.</p>
<p>In addition to the detection of a pathogenic <em>CHEK2</em> variant in two cases with use of the 84-gene virtual WES panel, actionable variants were also detected in the lesser-known cancer-associated genes <em>PTCH1</em> and <em>KIT</em>. <em>PTCH</em> is involved in the hereditary condition Nevoid basal cell carcinoma syndrome (NBCCS) or Gorlin syndrome (<a href="#B45" class="usa-link" aria-describedby="B45">45</a>, <a href="#B46" class="usa-link" aria-describedby="B46">46</a>). The gene has an autosomal dominant inheritance pattern with nearly complete penetrance and variable expressivity (<a href="#B47" class="usa-link" aria-describedby="B47">47</a>). PTCH1 is a transmembrane glycoprotein that is composed of 12 transmembrane domains. The syndrome is characterized by developmental abnormalities and tumor predisposition, with a diagnosis based on the occurrence of multiple basal cell carcinomas, palmar and plantar epidermal pits (<a href="#B48" class="usa-link" aria-describedby="B48">48</a>) and/or jaw keratocysts (<a href="#B48" class="usa-link" aria-describedby="B48">48</a>, <a href="#B49" class="usa-link" aria-describedby="B49">49</a>). This gene is also associated with ovarian fibromas diagnosed at a mean age of 30 years and potentially acts as a tumor suppressor gene (<a href="#B47" class="usa-link" aria-describedby="B47">47</a>), with many germline pathogenic variants since described in the literature. The <em>KIT</em> gene encodes for a protein located in the cell membrane of certain cell types and provides instructions to produce receptor tyrosine kinases, which are responsible for signal transmission from the cell surface into the cell through signal transduction. The KIT protein is activated by the binding of a growth factor, namely the stem cell factor. Together, they regulate a variety of crucial cellular processes such as proliferation and differentiation, cell survival and cell cycle control (<a href="#B50" class="usa-link" aria-describedby="B50">50</a>, <a href="#B51" class="usa-link" aria-describedby="B51">51</a>). The aberrant activation of KIT results in the deregulation of the signaling networks which has been associated with the progression of many cancer types such as melanoma, gastrointestinal stromal tumor, and stomach cancers (<a href="#B52" class="usa-link" aria-describedby="B52">52</a>–<a href="#B54" class="usa-link" aria-describedby="B54">54</a>).</p>
<p>The expansion of routine genetic testing from conventional <em>BRCA1/2</em> testing to multigene testing led to a relatively high diagnostic yield of 15%, with approximately one-third of positive cases (12/34, 35.3%) found to be known South African founder variants. Although no official cost-effectiveness analysis has been performed in South Africa, these results justify the incorporation of <em>BRCA1/2</em> founder variant testing in the screening algorithm recommended by Mampunye et al. (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>). Since transcriptional gene profiling routinely used in the private sector to prevent chemotherapy overtreatment in patients with early-stage hormone receptor-positive breast cancer is not available in the state sector, we modified the screening algorithm by omitting the assessment of RNA extracted from formalin-fixed paraffin embedded tumor biopsies. This is shown in <a href="#f2" class="usa-link">
<strong>Figure 2</strong>
</a>, starting with <em>BRCA1/2</em> founder variant testing extended to BRCA-expanded gene panel testing in high-risk cases based on the age at diagnosis and a strong family history of cancer. These clinical indicators form part of the WES pre-screen algorithm previously described by van der Merwe et al. (<a href="#B10" class="usa-link" aria-describedby="B10">10</a>) for risk stratification when considering prophylactic surgery or magnetic resonance imaging. With identification of low-to-moderate penetrance genes, clinical assessments such as body mass index (BMI) may help to inform intervention strategies targeted at gene–environment interaction to reduce recurrence risk. For unresolved familial cases and patients with treatment failure or medication side effects, proceeding to WES/WGS may be beneficial beyond a singular health concern or research objective.</p>
<figure class="fig xbox font-sm" id="f2"><h3 class="obj_head">Figure 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9768488_fonc-12-938561-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10db/9768488/76bf9fe61305/fonc-12-938561-g002.jpg" loading="lazy" height="444" width="661" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/f2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Pathology-supported genetic testing algorithm extending from <em>BRCA1/2</em> founder variant testing to whole exome/genome sequencing (WES/WGS) in unresolved cases following targeted multigene panel testing. BRCA Expanded gene panel gene panel is used in <em>BRCA1/2</em> founder variant-negative cases with a high familial risk profile based on early age at diagnosis and/or a strong family history of cancer. Clinical assessments such as body mass index (BMI) and relevant biochemical testing may be considered in genetically uncharacterised cases to assist with lifestyle-triggered and therapy-associated risk stratification (Modified with permission from Mampunye et al. (<a href="#B16" class="usa-link" aria-describedby="B16">16</a>).</p></figcaption></figure><p>While electronic gatekeeping regarding requirements for genetic testing has been implemented by the Department of Health to ensure that referring clinicians adhere to the new national guidelines, use of the newly designed point-of-care (POC) assay (<a href="#B8" class="usa-link" aria-describedby="B8">8</a>, <a href="#B16" class="usa-link" aria-describedby="B16">16</a>) as a first-tier test for all breast and ovarian cancer patients has the potential to not only reduce cancer incidence but also improve survival by identifying high-risk variants in patients in need of risk-reducing treatments. The rapid POC assay is inexpensive (estimated purchase price ZAR 1 000) and can be used for all breast and ovarian cancer patients, irrespective of the Manchester score, ethnicity, tumour subtype or a history of cancer in other family members. The integrated workflow from sample collection to nucleic acid sequence analysis makes it ideal for targeted genetic testing in any primary/rural health clinic with access to online genetic/genomic counseling support and genotype data export for independent expert review. Sample collection using buccal swabs for POC DNA testing could replace the more expensive (ZAR 2 508.54) laboratory-based founder variant detection assay once fully validated against confirmed positive and negative controls. Such a rapid screen may increase access into the right care pathway as the average South African female has very limited knowledge regarding potential risk factors, although most are aware that a breast or lump in the armpit could be a sign of disease (<a href="#B55" class="usa-link" aria-describedby="B55">55</a>, <a href="#B56" class="usa-link" aria-describedby="B56">56</a>). As both the two-gene assay and the multigene test are currently offered at the same price (ZAR 7 912.86), the expanded test will be more beneficial for patients, even though costly poly (ADP-ribose) inhibitors are not yet available to mutation carriers in the public sector.</p>
<p>Early detection is of the utmost importance, since South African patients have no or very limited access to specialized diagnostic procedures and targeted therapies such a Herceptin (ZAR 20 000 for a single dose). Scans and imaging are major cost drivers, ranging from ZAR 1 800 for a mammogram to ZAR 3 000 – 15 000 for MRI and CT scans (medical aid tariffs) (<a href="#B57" class="usa-link" aria-describedby="B57">57</a>). Regarding treatment, the costs for one episode of chemotherapy were calculated to be approximately ZAR 16 259 in the absence of any adverse events (<a href="#B58" class="usa-link" aria-describedby="B58">58</a>). This drastically increased to ZAR 36 465 for patients who developed neutropenia, the most common adverse event encountered during their study. Surgery as a primary treatment option ranged from ZAR 30 000 for a lumpectomy to ZAR 150 000 – 250 000 (according to medical aid tariffs - <a href="https://www.1life.co.za/blog/cost-treat-breast-cancer" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.1life.co.za/blog/cost-treat-breast-cancer</a>) for bilateral mastectomies that include reconstruction. The costs indicated were not compared to other countries especially on the African continent, due to population differences, varying cancer incidence, and different health funding systems. Based on a cost-effectiveness analysis performed in the United States of America and the United Kingdom regarding the implementation of unselected multigene testing for all (<a href="#B59" class="usa-link" aria-describedby="B59">59</a>), it may be advisable to permit high-risk multigene genetic testing for all patients affected with breast or ovarian cancer in South Africa. Currently, multigene panel testing for hereditary breast cancer internationally delivers on average a prevalence of 1-14% positivity in the non-<em>BRCA</em> genes but simultaneously is accompanied by a high level of VUSes (<a href="#B60" class="usa-link" aria-describedby="B60">60</a>). This is likely to eventually incur higher costs over time when evaluated for its benefits and may increase the anxiety of patients.</p>
<p>This study was limited by the number of genes studied using the 15-gene NGS panel; hence the parallel use of WES rendered sustainable through research grants and postgraduate student training that open many benefit-sharing opportunities (<a href="#B61" class="usa-link" aria-describedby="B61">61</a>). The challenges associated with selection of the most appropriate genes for panel testing may be addressed by an adaptive reporting system currently developed as part of WES/WGS research. More information is needed about the prevalence, penetrance, and increased risks associated with the variant spectrum identified in the study cohort. Multi-gene panel testing is not yet ready for non-specialized clinical use without clear guidelines as the identification of actional variants in the more unfamiliar genes such as <em>CDK12</em> and <em>MRE11</em>, remains a problem. As 13/319 of the breast cancer cases analyzed in this series were lobular carcinomas (4.1%), likely- to pathogenic variants in the pleiotropic <em>CDH1</em> gene (<a href="#B62" class="usa-link" aria-describedby="B62">62</a>) would have been missed. Studies are underway to adjust the 15-gene panel to include this gene, requiring knowledge of tumor pathology and other genes for which consensus risks and management guidelines exist, to advance towards better health care for our patients.</p></section><section id="s5"><h2 class="pmc_sec_title">Conclusions</h2>
<p>The elusive goal of selecting the right number and type of genes for breast and ovarian cancer pharmacodiagnostics can be achieved in future by application of pathology-supported genetic testing extending from <em>BRCA1/2</em> founder variant screening to multigene panel testing complemented by WES/WGS in genetically uninformative cases. The use of pathology to bring genetics into the treatment domain is in line with the framework for implementation of genomic medicine in Africa, substantiated by a readiness assessment (<a href="#B63" class="usa-link" aria-describedby="B63">63</a>) applied in this study focused on the cost implications reported. We conclude that multigene panel testing offers a viable improvement over <em>BRCA1/2</em>-only sequencing, by contributing to the positivity rate of actionable pathogenic variants in 15% of cases (48/319). This finding is in line with international data and confirmed the necessity for universal <em>BRCA1/2</em> founder variant screening extended to NGS in unresolved cases to help prevent morbidity and mortality. Despite major strides made over the past decade to catch up with first-world countries, uptake of genetic diagnostic services will not reach its full potential unless genomic literacy is increased. Only then will the new era of genomics truly have an impact on healthcare in Africa. It is the opinion of the authors to prioritize the screening of genes for which the results can be applied in clinical practice, while enriching the cancer genomics database through return of actionable WES/WGS results towards the implementation of a learning healthcare system.</p></section><section id="s6"><h2 class="pmc_sec_title">Contribution</h2>
<p>Targeted and exploratory NGS technologies was combined in this study to develop a comprehensive research-driven genetic testing service for breast and ovarian cancer in South Africa. This approach has unlimited potential regarding the number of genes accessible for implementation of personalized genomic medicine. In contrast to targeted NGS, WES is not restricted by the number of genes that can be selected for inclusion in a virtual panel that can be analysed simultaneously. However, base coverage is not uniform throughout the human genome and therefore targeted gene panel testing is preferred in a diagnostic setting. Since all the patients with likely- to pathogenic variants detected with the use of a 15-gene panel are eligible for targeted therapies and implementation of prevention strategies, their at-risk family members may also benefit from knowledge of the familial risks with treatment implications. Implementation of the 15-gene panel resulted in the incorporation of genetic results into routine patient care, by providing more informative results for clinical decision-making at no additional costs. Utilization of a pathology-supported genetic testing platform for return of actionable WES results obtained in parallel to targeted NGS in unresolved cases, effectively bridged the clinical implementation gap between research and service delivery.</p></section><section id="s7"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#SM1" class="usa-link">
<strong>Supplementary Material</strong>
</a>.</p></section><section id="s8"><h2 class="pmc_sec_title">Ethics statement</h2>
<p>The studies involving human participants were reviewed and approved by the Health Sciences Research Ethics Committee of the University of the Free State (UFS-HSD2021/0704/2202), South Africa. Provincial approval was also obtained from KwaZulu-Natal (KZ_202201_013), North-West Province (NW_202202_007) and the Western Cape (WC_202202_019) for the inclusion of their patients. Lastly, the National Health Laboratory Service permitted the use of the data (reference PR2110611). Translational research was performed under a collaborative material transfer and data sharing agreement (S006652) approved by Stellenbosch University, South Africa, including ethics reference numbers N09/08/224 and C19/06/020. The patients/participants provided their written informed consent to participate in this study.</p></section><section id="s9"><h2 class="pmc_sec_title">Author contributions</h2>
<p>NM, HC and JO made substantial contributions to the conception, design and completion of this project. NM, HS, and KN obtained ethics approval. NM and KN selected the data for analysis and performed the genetic studies together with HS, JO, and MK. MK provided scientific insight following a gap analysis and applied for funding for research translation into clinical practice. All authors contributed to the article and approved the submitted version.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors acknowledge Theanette Mulder, medical writer/editor, Faculty of Health Sciences, University of the Free State, for the technical and editorial preparation of the manuscript. Dr Phetole Mahasha and Rizwana Mia are acknowledged for project management as part of relevant SAMRC funding applications and Glaudina Loots of the South African Department of Science and Innovation for infrastructure development support. Dr Dawn Stephens, Technology Innovation Agency, South Africa, is acknowledged for driving the implementation of the Open Genome Project. Registered genetic counsellor, Dr Nicole van der Merwe is acknowledged for assistance with return of research results and her managerial role in the Open Genome Project.</p></section><section id="s10"><h2 class="pmc_sec_title">Funding</h2>
<p>The data presented in this article represent diagnostic and translational research results. Research reported in this publication was supported by the South African Medical Research Council with funds received from the South African Department of Science and Innovation (S006652). The South African BioDesign Initiative of the Department of Science and Innovation and the Technology Innovation Agency are acknowledged for funding part of this research under the Open Genome Project (grant number 401/01).</p></section><section id="s11"><h2 class="pmc_sec_title">Conflict of interest</h2>
<p>Prof Maritha Kotze is a non-executive director and shareholder of Gknowmix Pty Ltd., to facilitate genetic research translation into clinical practice. The other authors have no conflict of interest to declare.</p></section><section id="s12"><h2 class="pmc_sec_title">Publisher’s note</h2>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></section><section id="s13"><h2 class="pmc_sec_title">Supplementary material</h2>
<p>The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fonc.2022.938561/full#supplementary-material" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/articles/10.3389/fonc.2022.938561/full#supplementary-material</a>
</p>
<section class="sm xbox font-sm" id="SF1"><div class="caption p">
<span>Supplementary Figure 1</span><p>Confirmation of the large deletion involving exons 62 and 63 in <em>ATM</em> detected with the Oncomine™ BRCA Expanded panel using next-generation sequencing and confirmed with multiplex ligation-dependent probe amplification. <strong>(A)</strong> Visualization report for the next-generation sequencing data using Ion Reporter™ Genomic Viewer (IRGV). The copy number data representing the various <em>ATM</em> exons are enclosed in the black box. The reduction in copy number for exons 62 and 63 are circled. <strong>(B)</strong> Graphical multiplex ligation-dependent probe amplification presentation confirming the deletion of <em>ATM</em> exons 62 and 63 using GeneMarker® software for SALSA® MLPA® P0190-D1.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Image_1.jpg" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (75.9KB, jpg) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM1"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (682KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM2"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_2.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (695.3KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM3"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_3.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (697.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="SM4"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_4.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (657.4KB, docx) </sup>
</div></div></section></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>
Wendt C, Margolin S. Identifying breast cancer susceptibility genes - a review of the genetic background in familial breast cancer. Acta Oncol (2019) 58:135–46. doi:  10.1080/0284186X.2018.1529428
</cite> [<a href="https://doi.org/10.1080/0284186X.2018.1529428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30606073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Oncol&amp;title=Identifying%20breast%20cancer%20susceptibility%20genes%20-%20a%20review%20of%20the%20genetic%20background%20in%20familial%20breast%20cancer&amp;author=C%20Wendt&amp;author=S%20Margolin&amp;volume=58&amp;publication_year=2019&amp;pmid=30606073&amp;doi=10.1080/0284186X.2018.1529428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>
Yoshida R. Hereditary breast and ovarian cancer (HBOC): A review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer (2021) 28:1167–80. doi:  10.1007/s12282-020-01148-2
</cite> [<a href="https://doi.org/10.1007/s12282-020-01148-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8514387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32862296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer&amp;title=Hereditary%20breast%20and%20ovarian%20cancer%20(HBOC):%20A%20review%20of%20its%20molecular%20characteristics,%20screening,%20treatment,%20and%20prognosis&amp;author=R%20Yoshida&amp;volume=28&amp;publication_year=2021&amp;pmid=32862296&amp;doi=10.1007/s12282-020-01148-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>
Francies FZ, Wainstein T, De Leeneer K, Cairns A, Murdoch M, Nietz S, et al. 
<em>BRCA1</em>, <em>BRCA2</em> and <em>PALB2</em> mutations and <em>CHEK2</em> c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple-negative breast cancer. BMC Cancer (2015) 15:912–21. doi:  10.1186/s12885-015-1913-6
</cite> [<a href="https://doi.org/10.1186/s12885-015-1913-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4647511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26577449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=BRCA1,%20BRCA2%20and%20PALB2%20mutations%20and%20CHEK2%20c.1100delC%20in%20different%20South%20African%20ethnic%20groups%20diagnosed%20with%20premenopausal%20and/or%20triple-negative%20breast%20cancer&amp;author=FZ%20Francies&amp;author=T%20Wainstein&amp;author=K%20De%20Leeneer&amp;author=A%20Cairns&amp;author=M%20Murdoch&amp;volume=15&amp;publication_year=2015&amp;pmid=26577449&amp;doi=10.1186/s12885-015-1913-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>
Genetics of breast and gynecologic cancers (PDQ®) (2017). Available at: <a href="http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/HealthProfessional</a> (Accessed March 08, 2022).</cite>
</li>
<li id="B5">
<span class="label">5.</span><cite>
Van der Merwe NC, Combrink HM, Ntaita KS, Oosthuizen J. Prevalence of clinically relevant germline <em>BRCA</em> variants in a large unselected South African breast and ovarian cancer cohort: A public sector experience. Front Genet (2022) 13:834265. doi:  10.3389/fgene.2022.834265
</cite> [<a href="https://doi.org/10.3389/fgene.2022.834265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9024354/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35464868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=Prevalence%20of%20clinically%20relevant%20germline%20BRCA%20variants%20in%20a%20large%20unselected%20South%20African%20breast%20and%20ovarian%20cancer%20cohort:%20A%20public%20sector%20experience&amp;author=NC%20Van%20der%20Merwe&amp;author=HM%20Combrink&amp;author=KS%20Ntaita&amp;author=J%20Oosthuizen&amp;volume=13&amp;publication_year=2022&amp;pages=834265&amp;pmid=35464868&amp;doi=10.3389/fgene.2022.834265&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>
Van der Merwe NC, Hamel N, Schneider SR, Apffelstaedt JP, Wijnen JT, Foulkes WD. A founder <em>BRCA2</em> mutation in non-Afrikaner breast cancer patients of the Western cape of South Africa. Clin Genet (2012) 81:179–84. doi:  10.1111/j.1399-0004.2010.01617x
</cite> [<a href="https://doi.org/10.1111/j.1399-0004.2010.01617x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21204799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Genet&amp;title=A%20founder%20BRCA2%20mutation%20in%20non-Afrikaner%20breast%20cancer%20patients%20of%20the%20Western%20cape%20of%20South%20Africa&amp;author=NC%20Van%20der%20Merwe&amp;author=N%20Hamel&amp;author=SR%20Schneider&amp;author=JP%20Apffelstaedt&amp;author=JT%20Wijnen&amp;volume=81&amp;publication_year=2012&amp;pmid=21204799&amp;doi=10.1111/j.1399-0004.2010.01617x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of breast, ovarian, and contralateral breast cancer for <em>BRCA1</em> and <em>BRCA2</em> mutation carriers. JAMA (2017) 317:2402–16. doi:  10.1001/jama.2017.7112
</cite> [<a href="https://doi.org/10.1001/jama.2017.7112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28632866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Risks%20of%20breast,%20ovarian,%20and%20contralateral%20breast%20cancer%20for%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=KB%20Kuchenbaecker&amp;author=JL%20Hopper&amp;author=DR%20Barnes&amp;author=K-A%20Phillips&amp;author=TM%20Mooij&amp;volume=317&amp;publication_year=2017&amp;pmid=28632866&amp;doi=10.1001/jama.2017.7112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>
Oosthuizen J, Kotze MJ, van der Merwe N, Myburgh EJ, Bester P, van der Merwe NC. Globally rare <em>BRCA2</em> variants with founder haplotypes in the South African population: Implications for point-of-care testing based on a single-institution <em>BRCA1/2</em> next-generation sequencing study. Front Oncol (2021) 10:619469. doi:  10.3389/fonc.2020.619469
</cite> [<a href="https://doi.org/10.3389/fonc.2020.619469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7908826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33643918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Globally%20rare%20BRCA2%20variants%20with%20founder%20haplotypes%20in%20the%20South%20African%20population:%20Implications%20for%20point-of-care%20testing%20based%20on%20a%20single-institution%20BRCA1/2%20next-generation%20sequencing%20study&amp;author=J%20Oosthuizen&amp;author=MJ%20Kotze&amp;author=N%20van%20der%20Merwe&amp;author=EJ%20Myburgh&amp;author=P%20Bester&amp;volume=10&amp;publication_year=2021&amp;pages=619469&amp;pmid=33643918&amp;doi=10.3389/fonc.2020.619469&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>
Breast Cancer Association Consortium. Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, et al. Breast cancer risk genes - association analysis in more than 113,000 women. N Engl J Med (2021) 384:428–39. doi:  10.1056/NEJMoa1913948
</cite> [<a href="https://doi.org/10.1056/NEJMoa1913948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7611105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33471991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Breast%20cancer%20risk%20genes%20-%20association%20analysis%20in%20more%20than%20113,000%20women&amp;author=L%20Dorling&amp;author=S%20Carvalho&amp;author=J%20Allen&amp;author=A%20Gonz%C3%A1lez-Neira&amp;author=C%20Luccarini&amp;volume=384&amp;publication_year=2021&amp;pmid=33471991&amp;doi=10.1056/NEJMoa1913948&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>
Van der Merwe N, Peeters AV, Pienaar FM, Bezuidenhout J, van Rensburg SJ, Kotze MJ. Exome sequencing in a family with luminal-type breast cancer underpinned by variation in the methylation pathway. Int J Mol Sci (2017) 18:467. doi:  10.3390/ijms18020467
</cite> [<a href="https://doi.org/10.3390/ijms18020467" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5343999/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28241424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Exome%20sequencing%20in%20a%20family%20with%20luminal-type%20breast%20cancer%20underpinned%20by%20variation%20in%20the%20methylation%20pathway&amp;author=N%20Van%20der%20Merwe&amp;author=AV%20Peeters&amp;author=FM%20Pienaar&amp;author=J%20Bezuidenhout&amp;author=SJ%20van%20Rensburg&amp;volume=18&amp;publication_year=2017&amp;pages=467&amp;pmid=28241424&amp;doi=10.3390/ijms18020467&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>
Moremi KE, Scott CJ, de Jager LJ, Pienaar R, Zemlin AE, Kotze MJ. Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic <em>TP53</em> variants. Breast (2021) 56(1):S64–5.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Breast&amp;title=Implementation%20of%20a%20pathology-supported%20genetic%20testing%20framework%20for%20return%20of%20research%20results%20to%20family%20members%20of%20deceased%20breast%20cancer%20patients%20with%20somatic%20TP53%20variants&amp;author=KE%20Moremi&amp;author=CJ%20Scott&amp;author=LJ%20de%20Jager&amp;author=R%20Pienaar&amp;author=AE%20Zemlin&amp;volume=56&amp;issue=1&amp;publication_year=2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>
Torrorey-Sawe R, van der Merwe N, Mining SK, Kotze MJ. Pioneering informed consent for return of research results to breast cancer patients facing barriers to implementation of genomic medicine: The Kenyan <em>BRCA1/2</em> testing experience using whole exome sequencing. Front Genet (2020) 11:170(170). doi:  10.3389/fgene.2020.00170
</cite> [<a href="https://doi.org/10.3389/fgene.2020.00170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7089032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32231682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=Pioneering%20informed%20consent%20for%20return%20of%20research%20results%20to%20breast%20cancer%20patients%20facing%20barriers%20to%20implementation%20of%20genomic%20medicine:%20The%20Kenyan%20BRCA1/2%20testing%20experience%20using%20whole%20exome%20sequencing&amp;author=R%20Torrorey-Sawe&amp;author=N%20van%20der%20Merwe&amp;author=SK%20Mining&amp;author=MJ%20Kotze&amp;volume=11&amp;issue=170&amp;publication_year=2020&amp;pages=170&amp;pmid=32231682&amp;doi=10.3389/fgene.2020.00170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>
Peeters AV, van Heerden CJ, Kotze MJ. Whole exome sequencing revealed a novel 1-bp <em>PALB2</em> deletion mutation (D434fs) in a breast cancer patient with a <em>BRCA1</em> variant of uncertain clinical significance. Breast (2017) 32(Suppl 1):S44.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Breast&amp;title=Whole%20exome%20sequencing%20revealed%20a%20novel%201-bp%20PALB2%20deletion%20mutation%20(D434fs)%20in%20a%20breast%20cancer%20patient%20with%20a%20BRCA1%20variant%20of%20uncertain%20clinical%20significance&amp;author=AV%20Peeters&amp;author=CJ%20van%20Heerden&amp;author=MJ%20Kotze&amp;volume=32&amp;issue=Suppl%201&amp;publication_year=2017&amp;pages=S44&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>
Glanzmann B, Jooste T, Ghoor S, Gordon R, Mia R, Mao R, et al. Human whole genome sequencing in South Africa. Sci Rep (2021) 11:606.</cite> [<a href="https://doi.org/10.1038/s41598-020-79794-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7803990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33436733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Human%20whole%20genome%20sequencing%20in%20South%20Africa&amp;author=B%20Glanzmann&amp;author=T%20Jooste&amp;author=S%20Ghoor&amp;author=R%20Gordon&amp;author=R%20Mia&amp;volume=11&amp;publication_year=2021&amp;pages=606&amp;pmid=33436733&amp;doi=10.1038/s41598-020-79794-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>
Kotze MJ. Application of advanced molecular technology in the diagnosis and management of genetic disorders in South Africa. S Afr Med J (2016) 106:S114–8. doi:  10.7196/SAMJ.2016.v106i6.11012
</cite> [<a href="https://doi.org/10.7196/SAMJ.2016.v106i6.11012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27245544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=S%20Afr%20Med%20J&amp;title=Application%20of%20advanced%20molecular%20technology%20in%20the%20diagnosis%20and%20management%20of%20genetic%20disorders%20in%20South%20Africa&amp;author=MJ%20Kotze&amp;volume=106&amp;publication_year=2016&amp;pmid=27245544&amp;doi=10.7196/SAMJ.2016.v106i6.11012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>
Mampunye L, van der Merwe NC, Grant KA, Peeters AV, Torrorey-Sawe R, French DJ, et al. Pioneering <em>BRCA1/2</em> point-of-care testing for integration of germline and tumor genetics in breast cancer risk management: a vision for the future of translational pharmacogenomics. Front Oncol (2021) 11:619817. doi:  10.3389/fonc.2021.619817
</cite> [<a href="https://doi.org/10.3389/fonc.2021.619817" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8513538/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34660253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=Pioneering%20BRCA1/2%20point-of-care%20testing%20for%20integration%20of%20germline%20and%20tumor%20genetics%20in%20breast%20cancer%20risk%20management:%20a%20vision%20for%20the%20future%20of%20translational%20pharmacogenomics&amp;author=L%20Mampunye&amp;author=NC%20van%20der%20Merwe&amp;author=KA%20Grant&amp;author=AV%20Peeters&amp;author=R%20Torrorey-Sawe&amp;volume=11&amp;publication_year=2021&amp;pages=619817&amp;pmid=34660253&amp;doi=10.3389/fonc.2021.619817&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>
Wagener-Ryczek S, Merkelbach-Bruse S, Siemanowski J. Biomarkers for homologous recombination deficiency in cancer. J Pers Med (2021) 11:612. doi:  10.3390/jpm11070612
</cite> [<a href="https://doi.org/10.3390/jpm11070612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8304859/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34203281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pers%20Med&amp;title=Biomarkers%20for%20homologous%20recombination%20deficiency%20in%20cancer&amp;author=S%20Wagener-Ryczek&amp;author=S%20Merkelbach-Bruse&amp;author=J%20Siemanowski&amp;volume=11&amp;publication_year=2021&amp;pages=612&amp;pmid=34203281&amp;doi=10.3390/jpm11070612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>
Keung MY, Wu Y, Badar F, Vadgama JV. Response of breast cancer cells to PARP inhibitors is independent of <em>BRCA</em> status. J Clin Med (2020) 9:940. doi:  10.3390/jcm9040940
</cite> [<a href="https://doi.org/10.3390/jcm9040940" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7231148/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32235451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Med&amp;title=Response%20of%20breast%20cancer%20cells%20to%20PARP%20inhibitors%20is%20independent%20of%20BRCA%20status&amp;author=MY%20Keung&amp;author=Y%20Wu&amp;author=F%20Badar&amp;author=JV%20Vadgama&amp;volume=9&amp;publication_year=2020&amp;pages=940&amp;pmid=32235451&amp;doi=10.3390/jcm9040940&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>
National Comprehensive Cancer Network (NCCN) . NCCN guidelines version 2.2022 (2022). Available at: <a href="https://www.nccn.org/guidelines/guidelines-detail?category=2&amp;id=1503" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.nccn.org/guidelines/guidelines-detail?category=2&amp;id=1503</a> (Accessed April 19, 2022).</cite>
</li>
<li id="B20">
<span class="label">20.</span><cite>
Sung P, Klein H. Mechanisms of homologous recombination: mediators and helicases take on regulatory functions. Nat Rev Mol Cell Biol (2006) 7:739–50. doi:  10.1038/nrm2008
</cite> [<a href="https://doi.org/10.1038/nrm2008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16926856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Rev%20Mol%20Cell%20Biol&amp;title=Mechanisms%20of%20homologous%20recombination:%20mediators%20and%20helicases%20take%20on%20regulatory%20functions&amp;author=P%20Sung&amp;author=H%20Klein&amp;volume=7&amp;publication_year=2006&amp;pmid=16926856&amp;doi=10.1038/nrm2008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21">
<span class="label">21.</span><cite>
Krejci L, Altmannova V, Spirek M, Zhao X. Homologous recombination and its regulation. Nucleic Acids Res (2012) 40:5795–818. doi:  10.1093/nar/gks270
</cite> [<a href="https://doi.org/10.1093/nar/gks270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3401455/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22467216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=Homologous%20recombination%20and%20its%20regulation&amp;author=L%20Krejci&amp;author=V%20Altmannova&amp;author=M%20Spirek&amp;author=X%20Zhao&amp;volume=40&amp;publication_year=2012&amp;pmid=22467216&amp;doi=10.1093/nar/gks270&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22">
<span class="label">22.</span><cite>
Valerie K, Povirk LF. Regulation and mechanisms of mammalian double-strand break repair. Oncogene (2003) 22:5792–812. doi:  10.1038/sj.onc.1206679
</cite> [<a href="https://doi.org/10.1038/sj.onc.1206679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12947387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Regulation%20and%20mechanisms%20of%20mammalian%20double-strand%20break%20repair&amp;author=K%20Valerie&amp;author=LF%20Povirk&amp;volume=22&amp;publication_year=2003&amp;pmid=12947387&amp;doi=10.1038/sj.onc.1206679&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23">
<span class="label">23.</span><cite>
Badie S, Escandell JM, Bouwman P, Carlos AR, Thanasoula M, Gallardo MM, et al. BRCA2 acts as a RAD51 loader to facilitate telomere replication and capping. Nat Struct Mol Biol (2010) 17:1461–9. doi:  10.1038/nsmb.1943
</cite> [<a href="https://doi.org/10.1038/nsmb.1943" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2998174/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21076401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Struct%20Mol%20Biol&amp;title=BRCA2%20acts%20as%20a%20RAD51%20loader%20to%20facilitate%20telomere%20replication%20and%20capping&amp;author=S%20Badie&amp;author=JM%20Escandell&amp;author=P%20Bouwman&amp;author=AR%20Carlos&amp;author=M%20Thanasoula&amp;volume=17&amp;publication_year=2010&amp;pmid=21076401&amp;doi=10.1038/nsmb.1943&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24">
<span class="label">24.</span><cite>
Tsang SS, Chow SA, Radding CM. Networks of DNA and RecA protein are intermediates in homologous pairing. Biochemistry (1985) 24:3226–32. doi:  10.1021/bi00334a023
</cite> [<a href="https://doi.org/10.1021/bi00334a023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3161539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Networks%20of%20DNA%20and%20RecA%20protein%20are%20intermediates%20in%20homologous%20pairing&amp;author=SS%20Tsang&amp;author=SA%20Chow&amp;author=CM%20Radding&amp;volume=24&amp;publication_year=1985&amp;pmid=3161539&amp;doi=10.1021/bi00334a023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25">
<span class="label">25.</span><cite>
Kotze MJ, Lückhoff HK, Peeters AV, Baatjes K, Schoeman M, van der Merwe L, et al. Genomic medicine and risk prediction across the disease spectrum. Crit Rev Clin Lab Sci (2015) 19:1–15.</cite> [<a href="https://doi.org/10.3109/10408363.2014.997930" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25597499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Crit%20Rev%20Clin%20Lab%20Sci&amp;title=Genomic%20medicine%20and%20risk%20prediction%20across%20the%20disease%20spectrum&amp;author=MJ%20Kotze&amp;author=HK%20L%C3%BCckhoff&amp;author=AV%20Peeters&amp;author=K%20Baatjes&amp;author=M%20Schoeman&amp;volume=19&amp;publication_year=2015&amp;pages=1-15&amp;pmid=25597499&amp;doi=10.3109/10408363.2014.997930&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26">
<span class="label">26.</span><cite>
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 16:1215. doi:  10.1093/nar/16.3.1215
</cite> [<a href="https://doi.org/10.1093/nar/16.3.1215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC334765/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3344216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=A%20simple%20salting%20out%20procedure%20for%20extracting%20DNA%20from%20human%20nucleated%20cells&amp;author=SA%20Miller&amp;author=DD%20Dykes&amp;author=HF%20Polesky&amp;volume=16&amp;publication_year=1988&amp;pages=1215&amp;pmid=3344216&amp;doi=10.1093/nar/16.3.1215&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27">
<span class="label">27.</span><cite>
Brandt T, Sack LM, Arjona D, Tan D, Mei H, Cui H, et al. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants. Genet Med (2020) 22:336–44. doi:  10.1038/s41436-019-0655-2
</cite> [<a href="https://doi.org/10.1038/s41436-019-0655-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31534211/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Adapting%20ACMG/AMP%20sequence%20variant%20classification%20guidelines%20for%20single-gene%20copy%20number%20variants&amp;author=T%20Brandt&amp;author=LM%20Sack&amp;author=D%20Arjona&amp;author=D%20Tan&amp;author=H%20Mei&amp;volume=22&amp;publication_year=2020&amp;pmid=31534211&amp;doi=10.1038/s41436-019-0655-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28">
<span class="label">28.</span><cite>
Okunola AO. Investigation of the role of vitamin D metabolism in South African breast cancer patients using a pathology-supported genetic testing platform (2020). Stellenbosch, South Africa: University of Stellenbosch. Available at: <a href="https://scholar.sun.ac.za/handle/10019.1/108186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://scholar.sun.ac.za/handle/10019.1/108186</a> (Accessed February 15, 2022).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Investigation%20of%20the%20role%20of%20vitamin%20D%20metabolism%20in%20South%20African%20breast%20cancer%20patients%20using%20a%20pathology-supported%20genetic%20testing%20platform&amp;author=AO%20Okunola&amp;publication_year=2020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29">
<span class="label">29.</span><cite>
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med (2015) 17:405–24. doi:  10.1038/gim.2015.30
</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20a%20joint%20consensus%20recommendation%20of%20the%20American%20college%20of%20medical%20genetics%20and%20genomics%20and%20the%20association%20for%20molecular%20pathology&amp;author=S%20Richards&amp;author=N%20Aziz&amp;author=S%20Bale&amp;author=D%20Bick&amp;author=S%20Das&amp;volume=17&amp;publication_year=2015&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30">
<span class="label">30.</span><cite>
Fortuno C, Lee K, Olivier M, Pesaran T, Mai PL, de Andrade KC, et al. Specifications of the ACMG/AMP variant interpretation guidelines for germline <em>TP53</em> variants. Hum Mutat (2021) 42:223–36. doi:  10.1002/humu.24150
</cite> [<a href="https://doi.org/10.1002/humu.24150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8374922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33300245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum%20Mutat&amp;title=Specifications%20of%20the%20ACMG/AMP%20variant%20interpretation%20guidelines%20for%20germline%20TP53%20variants&amp;author=C%20Fortuno&amp;author=K%20Lee&amp;author=M%20Olivier&amp;author=T%20Pesaran&amp;author=PL%20Mai&amp;volume=42&amp;publication_year=2021&amp;pmid=33300245&amp;doi=10.1002/humu.24150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31">
<span class="label">31.</span><cite>
Feliubadaló L, Moles-Fernández A, Santamariña-Pena M, Sánchez AT, López-Novo A, Porras LM, et al. A collaborative effort to define classification criteria for <em>ATM</em> variants in hereditary cancer patients. Clin Chem (2021) 67:518–33. doi:  10.1093/clinchem/hvaa250
</cite> [<a href="https://doi.org/10.1093/clinchem/hvaa250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33280026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=A%20collaborative%20effort%20to%20define%20classification%20criteria%20for%20ATM%20variants%20in%20hereditary%20cancer%20patients&amp;author=L%20Feliubadal%C3%B3&amp;author=A%20Moles-Fern%C3%A1ndez&amp;author=M%20Santamari%C3%B1a-Pena&amp;author=AT%20S%C3%A1nchez&amp;author=A%20L%C3%B3pez-Novo&amp;volume=67&amp;publication_year=2021&amp;pmid=33280026&amp;doi=10.1093/clinchem/hvaa250&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32">
<span class="label">32.</span><cite>
Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics (2019) 35:1978–80. doi:  10.1093/bioinformatics/bty892
</cite> [<a href="https://doi.org/10.1093/bioinformatics/bty892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6546127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30376034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=VarSome:%20the%20human%20genomic%20variant%20search%20engine&amp;author=C%20Kopanos&amp;author=V%20Tsiolkas&amp;author=A%20Kouris&amp;author=CE%20Chapple&amp;author=MA%20Aguilera&amp;volume=35&amp;publication_year=2019&amp;pmid=30376034&amp;doi=10.1093/bioinformatics/bty892&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33">
<span class="label">33.</span><cite>
Scafe C, Zhu Y, Yang C, Tseng Y-T, McKnight B, Farfan F, et al. Abstract 2505: The Oncomine BRCA expanded next-generation sequencing assay: development and analytical validation of a new panel for detection of SNV, insertions, deletions and copy number variants in a panel of 15 genes involved in homologous recombination repair of double-strand break DNA damage. Cancer Res (2020) 80:2505. doi:  10.1158/1538-7445.AM2020-2505
</cite> [<a href="https://doi.org/10.1158/1538-7445.AM2020-2505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Abstract%202505:%20The%20Oncomine%20BRCA%20expanded%20next-generation%20sequencing%20assay:%20development%20and%20analytical%20validation%20of%20a%20new%20panel%20for%20detection%20of%20SNV,%20insertions,%20deletions%20and%20copy%20number%20variants%20in%20a%20panel%20of%2015%20genes%20involved%20in%20homologous%20recombination%20repair%20of%20double-strand%20break%20DNA%20damage&amp;author=C%20Scafe&amp;author=Y%20Zhu&amp;author=C%20Yang&amp;author=Y-T%20Tseng&amp;author=B%20McKnight&amp;volume=80&amp;publication_year=2020&amp;pages=2505&amp;doi=10.1158/1538-7445.AM2020-2505&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34">
<span class="label">34.</span><cite>
Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature (2005) 434:917–21. doi:  10.1038/nature03445
</cite> [<a href="https://doi.org/10.1038/nature03445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15829967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Targeting%20the%20DNA%20repair%20defect%20in%20BRCA%20mutant%20cells%20as%20a%20therapeutic%20strategy&amp;author=H%20Farmer&amp;author=N%20McCabe&amp;author=CJ%20Lord&amp;author=AN%20Tutt&amp;author=DA%20Johnson&amp;volume=434&amp;publication_year=2005&amp;pmid=15829967&amp;doi=10.1038/nature03445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35">
<span class="label">35.</span><cite>
Keung MY, Wu Y, Vadgama JV. PARP inhibitors as a therapeutic agent for homologous recombination deficiency in breast cancers. J Clin Med (2019) 8:435. doi:  10.3390/jcm8040435
</cite> [<a href="https://doi.org/10.3390/jcm8040435" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6517993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30934991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Med&amp;title=PARP%20inhibitors%20as%20a%20therapeutic%20agent%20for%20homologous%20recombination%20deficiency%20in%20breast%20cancers&amp;author=MY%20Keung&amp;author=Y%20Wu&amp;author=JV%20Vadgama&amp;volume=8&amp;publication_year=2019&amp;pages=435&amp;pmid=30934991&amp;doi=10.3390/jcm8040435&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36">
<span class="label">36.</span><cite>
Reeves MD, Yawitch TM, van der Merwe NC, Van den Berg HJ, Dreyer G, Van Rensburg EJ. 
<em>BRCA1</em> mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families. Int J Cancer (2004) 110:677–82. doi:  10.1002/ijc.20186
</cite> [<a href="https://doi.org/10.1002/ijc.20186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15146556/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cancer&amp;title=BRCA1%20mutations%20in%20South%20African%20breast%20and/or%20ovarian%20cancer%20families:%20evidence%20of%20a%20novel%20founder%20mutation%20in%20Afrikaner%20families&amp;author=MD%20Reeves&amp;author=TM%20Yawitch&amp;author=NC%20van%20der%20Merwe&amp;author=HJ%20Van%20den%20Berg&amp;author=G%20Dreyer&amp;volume=110&amp;publication_year=2004&amp;pmid=15146556&amp;doi=10.1002/ijc.20186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37">
<span class="label">37.</span><cite>
Van der Merwe NC, van Rensburg EJ. Hereditary breast/ovarian cancer and <em>BRCA</em> mutations: A South African perspective. Curr Oncol (2009) 16:91–110. doi:  10.3747/co.vi6i5.529
</cite> [<a href="https://doi.org/10.3747/co.vi6i5.529" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Oncol&amp;title=Hereditary%20breast/ovarian%20cancer%20and%20BRCA%20mutations:%20A%20South%20African%20perspective&amp;author=NC%20Van%20der%20Merwe&amp;author=EJ%20van%20Rensburg&amp;volume=16&amp;publication_year=2009&amp;pages=91-110&amp;doi=10.3747/co.vi6i5.529&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38">
<span class="label">38.</span><cite>
Eygelaar D, van Rensburg EJ, Joubert F. Germline sequence variants contributing to cancer susceptibility in South African breast cancer patients of African ancestry. Sci Rep (2022) 12:802. doi:  10.1038/s41598-022-04791-1
</cite> [<a href="https://doi.org/10.1038/s41598-022-04791-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8763903/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35039564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Germline%20sequence%20variants%20contributing%20to%20cancer%20susceptibility%20in%20South%20African%20breast%20cancer%20patients%20of%20African%20ancestry&amp;author=D%20Eygelaar&amp;author=EJ%20van%20Rensburg&amp;author=F%20Joubert&amp;volume=12&amp;publication_year=2022&amp;pages=802&amp;pmid=35039564&amp;doi=10.1038/s41598-022-04791-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39">
<span class="label">39.</span><cite>
Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol (2017) 3:1190–94. doi:  10.1001/jamaoncol.2017.0424
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2017.0424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5599323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28418444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Associations%20between%20cancer%20predisposition%20testing%20panel%20genes%20and%20breast%20cancer&amp;author=FJ%20Couch&amp;author=H%20Shimelis&amp;author=C%20Hu&amp;author=SN%20Hart&amp;author=EC%20Polley&amp;volume=3&amp;publication_year=2017&amp;pmid=28418444&amp;doi=10.1001/jamaoncol.2017.0424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40">
<span class="label">40.</span><cite>
Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH. Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep (2009) 10:990–6. doi:  10.1038/embor.2009.126
</cite> [<a href="https://doi.org/10.1038/embor.2009.126" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2750052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19609323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Rep&amp;title=Structural%20basis%20for%20recruitment%20of%20BRCA2%20by%20PALB2&amp;author=AW%20Oliver&amp;author=S%20Swift&amp;author=CJ%20Lord&amp;author=A%20Ashworth&amp;author=LH%20Pearl&amp;volume=10&amp;publication_year=2009&amp;pmid=19609323&amp;doi=10.1038/embor.2009.126&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41">
<span class="label">41.</span><cite>
Ahmed SS, Rifat ZT, Lohia R, Campbell AJ, Dunker AK, Rahman MS, et al. Characterization of intrinsically disordered regions in proteins informed by human genetic diversity. PLoS Comput Biol (2022) 18:e1009911. doi:  10.1371/journal.pcbi.1009911
</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1009911" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8942211/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35275927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Comput%20Biol&amp;title=Characterization%20of%20intrinsically%20disordered%20regions%20in%20proteins%20informed%20by%20human%20genetic%20diversity&amp;author=SS%20Ahmed&amp;author=ZT%20Rifat&amp;author=R%20Lohia&amp;author=AJ%20Campbell&amp;author=AK%20Dunker&amp;volume=18&amp;publication_year=2022&amp;pages=e1009911&amp;pmid=35275927&amp;doi=10.1371/journal.pcbi.1009911&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42">
<span class="label">42.</span><cite>
Awasthi S. Haploinsufficiency interactions of RALBP1 and TP53 in carcinogenesis. Cancers (2021) 13:255. doi:  10.3390/cancers13020255
</cite> [<a href="https://doi.org/10.3390/cancers13020255" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7827952/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33445456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Haploinsufficiency%20interactions%20of%20RALBP1%20and%20TP53%20in%20carcinogenesis&amp;author=S%20Awasthi&amp;volume=13&amp;publication_year=2021&amp;pages=255&amp;pmid=33445456&amp;doi=10.3390/cancers13020255&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43">
<span class="label">43.</span><cite>
Baatjes KJ, Schoeman M, Okunola A, van der Merwe NC, Kotze MJ. Integrating whole exome sequencing into the breast cancer clinical setting: Process and outcome. 66th Faculty of Medicine and Health Sciences, Annual Academic Day, 31 August 2022-01 September 2022. Cape Town, South Africa:  (2022). <a href="https://urldefense.com/v3/__https://www.sun.ac.za/english/faculty/healthsciences/aad/Documents/2022/Final*20Programme*20-*2066th*20Annual*20Academic*20Day*20-*2031*20Aug*202022-red.pdf__;JSUlJSUlJSUlJQ!!LRJdiIM!E22_VIGg9VQoV0OHIfGmC1NcMGuS7EHd14B-tMmevweRXx06M2Kc7SgnTqHIcn-agVep7Qa1LPFIhDdVTtTq9CYB%24" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sun.ac.za/english/faculty/healthsciences/aad/Documents/2022/Final%20Programme%20-%2066th%20Annual%20Academic%20Day%20-%2031%20Aug%202022-red.pdf</a>
</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Integrating%20whole%20exome%20sequencing%20into%20the%20breast%20cancer%20clinical%20setting:%20Process%20and%20outcome.%2066th%20Faculty%20of%20Medicine%20and%20Health%20Sciences,%20Annual%20Academic%20Day,%2031%20August%202022-01%20September%202022&amp;author=KJ%20Baatjes&amp;author=M%20Schoeman&amp;author=A%20Okunola&amp;author=NC%20van%20der%20Merwe&amp;author=MJ%20Kotze&amp;publication_year=2022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44">
<span class="label">44.</span><cite>
Suwinski P, Ong C, Ling MHT, Poh YM, Khan AM, Ong HS. Advancing personalized medicine through the application of whole exome sequencing and big data analytics. Front Genet (2019) 10:49. doi:  10.3389/fgene.2019.00049
</cite> [<a href="https://doi.org/10.3389/fgene.2019.00049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6379253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30809243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=Advancing%20personalized%20medicine%20through%20the%20application%20of%20whole%20exome%20sequencing%20and%20big%20data%20analytics&amp;author=P%20Suwinski&amp;author=C%20Ong&amp;author=MHT%20Ling&amp;author=YM%20Poh&amp;author=AM%20Khan&amp;volume=10&amp;publication_year=2019&amp;pages=49&amp;pmid=30809243&amp;doi=10.3389/fgene.2019.00049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45">
<span class="label">45.</span><cite>
Farndon PA, Del Mastro RG, Evans DG, Kilpatrick MW. Location of gene for gorlin syndrome. Lancet (1992) 339:581–2. doi:  10.1016/0140-6736(92)90868-4
</cite> [<a href="https://doi.org/10.1016/0140-6736(92)90868-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1347096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Location%20of%20gene%20for%20gorlin%20syndrome&amp;author=PA%20Farndon&amp;author=RG%20Del%20Mastro&amp;author=DG%20Evans&amp;author=MW%20Kilpatrick&amp;volume=339&amp;publication_year=1992&amp;pmid=1347096&amp;doi=10.1016/0140-6736(92)90868-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46">
<span class="label">46.</span><cite>
Gailani MR, Bale SJ, Leffell DJ, DiGiovanna JJ, Peck GL, Poliak S, et al. Developmental defects in gorlin syndrome related to a putative tumor suppressor gene on chromosome 9. Cell (1992) 69:111–7. doi:  10.1016/0092-8674(92)90122-s
</cite> [<a href="https://doi.org/10.1016/0092-8674(92)90122-s" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1348213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Developmental%20defects%20in%20gorlin%20syndrome%20related%20to%20a%20putative%20tumor%20suppressor%20gene%20on%20chromosome%209&amp;author=MR%20Gailani&amp;author=SJ%20Bale&amp;author=DJ%20Leffell&amp;author=JJ%20DiGiovanna&amp;author=GL%20Peck&amp;volume=69&amp;publication_year=1992&amp;pmid=1348213&amp;doi=10.1016/0092-8674(92)90122-s&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47">
<span class="label">47.</span><cite>
Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med (2004) 6:530–9. doi:  10.1097/01.GIM.0000144188.15902.C4
</cite> [<a href="https://doi.org/10.1097/01.GIM.0000144188.15902.C4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15545751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Nevoid%20basal%20cell%20carcinoma%20(Gorlin)%20syndrome&amp;author=RJ%20Gorlin&amp;volume=6&amp;publication_year=2004&amp;pmid=15545751&amp;doi=10.1097/01.GIM.0000144188.15902.C4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48">
<span class="label">48.</span><cite>
Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet (1997) 69:299–308.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9096761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Med%20Genet&amp;title=Clinical%20manifestations%20in%20105%20persons%20with%20nevoid%20basal%20cell%20carcinoma%20syndrome&amp;author=VE%20Kimonis&amp;author=AM%20Goldstein&amp;author=B%20Pastakia&amp;author=ML%20Yang&amp;author=R%20Kase&amp;volume=69&amp;publication_year=1997&amp;pages=299-308&amp;pmid=9096761&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49">
<span class="label">49.</span><cite>
Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis (2008) 3:32. doi:  10.1186/1750-1172-3-32
</cite> [<a href="https://doi.org/10.1186/1750-1172-3-32" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2607262/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19032739/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet%20J%20Rare%20Dis&amp;title=Nevoid%20basal%20cell%20carcinoma%20syndrome%20(Gorlin%20syndrome)&amp;author=L%20Lo%20Muzio&amp;volume=3&amp;publication_year=2008&amp;pages=32&amp;pmid=19032739&amp;doi=10.1186/1750-1172-3-32&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50">
<span class="label">50.</span><cite>
Roskoski R. Structure and regulation of kit protein-tyrosine kinase–the stem cell factor receptor. Biochem Biophys Res Commun (2005) 338:1307–15. doi:  10.1016/j.bbrc.2005.09.150
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2005.09.150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16226710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Structure%20and%20regulation%20of%20kit%20protein-tyrosine%20kinase%E2%80%93the%20stem%20cell%20factor%20receptor&amp;author=R%20Roskoski&amp;volume=338&amp;publication_year=2005&amp;pmid=16226710&amp;doi=10.1016/j.bbrc.2005.09.150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51">
<span class="label">51.</span><cite>
Opatowsky Y, Lax I, Tomé F, Bleichert F, Unger VM, Schlessinger J. Structure, domain organization, and different conformational states of stem cell factor-induced intact KIT dimers. Proc Natl Acad Sci U S A (2014) 111:1772–77. doi:  10.1073/pnas.1323254111
</cite> [<a href="https://doi.org/10.1073/pnas.1323254111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3918759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24449920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;title=Structure,%20domain%20organization,%20and%20different%20conformational%20states%20of%20stem%20cell%20factor-induced%20intact%20KIT%20dimers&amp;author=Y%20Opatowsky&amp;author=I%20Lax&amp;author=F%20Tom%C3%A9&amp;author=F%20Bleichert&amp;author=VM%20Unger&amp;volume=111&amp;publication_year=2014&amp;pmid=24449920&amp;doi=10.1073/pnas.1323254111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52">
<span class="label">52.</span><cite>
Kitamura Y, Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci (2004) 61:2924–31. doi:  10.1007/s00018-004-4273-y
</cite> [<a href="https://doi.org/10.1007/s00018-004-4273-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11924580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15583854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Mol%20Life%20Sci&amp;title=Kit%20as%20a%20human%20oncogenic%20tyrosine%20kinase&amp;author=Y%20Kitamura&amp;author=S%20Hirotab&amp;volume=61&amp;publication_year=2004&amp;pmid=15583854&amp;doi=10.1007/s00018-004-4273-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53">
<span class="label">53.</span><cite>
Gilreath J, Tchertanov L, Deininger M. Novel approaches to treating advanced systemic mastocytosis. Clin Pharmaco Adv (2019) 11:77–92. doi:  10.2147/CPAA.S206615
</cite> [<a href="https://doi.org/10.2147/CPAA.S206615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6630092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31372066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmaco%20Adv&amp;title=Novel%20approaches%20to%20treating%20advanced%20systemic%20mastocytosis&amp;author=J%20Gilreath&amp;author=L%20Tchertanov&amp;author=M%20Deininger&amp;volume=11&amp;publication_year=2019&amp;pages=77-92&amp;pmid=31372066&amp;doi=10.2147/CPAA.S206615&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54">
<span class="label">54.</span><cite>
Pham DDM, Guhan S, Tsao H. KIT and melanoma: Biological insights and clinical implications. Yonsei Med J (2020) 61:562–71. doi:  10.3349/ymj.2020.61.7.562
</cite> [<a href="https://doi.org/10.3349/ymj.2020.61.7.562" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7329741/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32608199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Yonsei%20Med%20J&amp;title=KIT%20and%20melanoma:%20Biological%20insights%20and%20clinical%20implications&amp;author=DDM%20Pham&amp;author=S%20Guhan&amp;author=H%20Tsao&amp;volume=61&amp;publication_year=2020&amp;pmid=32608199&amp;doi=10.3349/ymj.2020.61.7.562&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55">
<span class="label">55.</span><cite>
Trupe LA, Rositch A, Dickerson L, Lucas S, Harvey SC. Knowledge and attitudes about breast cancer in Limpopo, South Africa. J Glob Oncol (2017) 3:509–14. doi:  10.1200/JGO.2016.008102
</cite> [<a href="https://doi.org/10.1200/JGO.2016.008102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5646900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29094090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Glob%20Oncol&amp;title=Knowledge%20and%20attitudes%20about%20breast%20cancer%20in%20Limpopo,%20South%20Africa&amp;author=LA%20Trupe&amp;author=A%20Rositch&amp;author=L%20Dickerson&amp;author=S%20Lucas&amp;author=SC%20Harvey&amp;volume=3&amp;publication_year=2017&amp;pmid=29094090&amp;doi=10.1200/JGO.2016.008102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56">
<span class="label">56.</span><cite>
Joffe M, Ayeni O, Norris SA, McCormack VA, Ruff P, Das I, et al. Barriers to early presentation of breast cancer among women in Soweto, South Africa. PLoS One (2018) 13:e0192071. doi:  10.1371/journal.pone.0192071
</cite> [<a href="https://doi.org/10.1371/journal.pone.0192071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5796726/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29394271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Barriers%20to%20early%20presentation%20of%20breast%20cancer%20among%20women%20in%20Soweto,%20South%20Africa&amp;author=M%20Joffe&amp;author=O%20Ayeni&amp;author=SA%20Norris&amp;author=VA%20McCormack&amp;author=P%20Ruff&amp;volume=13&amp;publication_year=2018&amp;pages=e0192071&amp;pmid=29394271&amp;doi=10.1371/journal.pone.0192071&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57">
<span class="label">57.</span><cite>
Lipschitz S. Screening mammography with special reference to guidelines in South Africa. S Afr J Rad (2018) 22:a1370. doi:  10.4102/sajr.v22i2.1370
</cite> [<a href="https://doi.org/10.4102/sajr.v22i2.1370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6837783/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31754518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=S%20Afr%20J%20Rad&amp;title=Screening%20mammography%20with%20special%20reference%20to%20guidelines%20in%20South%20Africa&amp;author=S%20Lipschitz&amp;volume=22&amp;publication_year=2018&amp;pages=a1370&amp;pmid=31754518&amp;doi=10.4102/sajr.v22i2.1370&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58">
<span class="label">58.</span><cite>
Guzha NT, Thebe T, Butler N, Valodia PN. Development of a method to determine the cost of breast cancer treatment with chemotherapy at Groote Schuur hospital, Cape Town, South Africa. S Afr Med J (2020) 110:296–301. doi:  10.7196/SAMJ.2020.v110i4.14204
</cite> [<a href="https://doi.org/10.7196/SAMJ.2020.v110i4.14204" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32657741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=S%20Afr%20Med%20J&amp;title=Development%20of%20a%20method%20to%20determine%20the%20cost%20of%20breast%20cancer%20treatment%20with%20chemotherapy%20at%20Groote%20Schuur%20hospital,%20Cape%20Town,%20South%20Africa&amp;author=NT%20Guzha&amp;author=T%20Thebe&amp;author=N%20Butler&amp;author=PN%20Valodia&amp;volume=110&amp;publication_year=2020&amp;pages=296-301&amp;pmid=32657741&amp;doi=10.7196/SAMJ.2020.v110i4.14204&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59">
<span class="label">59.</span><cite>
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, et al. Cost-effectiveness analysis of multigene testing for all patients with breast cancer. JAMA Oncol (2019) 5:1718–30. doi:  10.1001/jamaoncol.2019.3323
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2019.3323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6777250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31580391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol&amp;title=Cost-effectiveness%20analysis%20of%20multigene%20testing%20for%20all%20patients%20with%20breast%20cancer&amp;author=L%20Sun&amp;author=A%20Brentnall&amp;author=S%20Patel&amp;author=DSM%20Buist&amp;author=EJA%20Bowles&amp;volume=5&amp;publication_year=2019&amp;pmid=31580391&amp;doi=10.1001/jamaoncol.2019.3323&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60">
<span class="label">60.</span><cite>
Monteiro AN, Bouwman P, Kousholt AN, Eccles DM, Millot GA, Masson JY, et al. Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation. J Med Genet (2020) 57:509–18. doi:  10.1136/jmedgenet-2019-106368
</cite> [<a href="https://doi.org/10.1136/jmedgenet-2019-106368" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7390672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32152249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Variants%20of%20uncertain%20clinical%20significance%20in%20hereditary%20breast%20and%20ovarian%20cancer%20genes:%20best%20practices%20in%20functional%20analysis%20for%20clinical%20annotation&amp;author=AN%20Monteiro&amp;author=P%20Bouwman&amp;author=AN%20Kousholt&amp;author=DM%20Eccles&amp;author=GA%20Millot&amp;volume=57&amp;publication_year=2020&amp;pmid=32152249&amp;doi=10.1136/jmedgenet-2019-106368&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61">
<span class="label">61.</span><cite>
Van der Merwe N, Ramesar R, De Vries J. Whole exome sequencing in South Africa: Stakeholder views on return of individual research results and incidental findings. Front Genet (2022) 13:864822. doi:  10.3389/fgene.2022.864822
</cite> [<a href="https://doi.org/10.3389/fgene.2022.864822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9216214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35754817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=Whole%20exome%20sequencing%20in%20South%20Africa:%20Stakeholder%20views%20on%20return%20of%20individual%20research%20results%20and%20incidental%20findings&amp;author=N%20Van%20der%20Merwe&amp;author=R%20Ramesar&amp;author=J%20De%20Vries&amp;volume=13&amp;publication_year=2022&amp;pages=864822&amp;pmid=35754817&amp;doi=10.3389/fgene.2022.864822&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62">
<span class="label">62.</span><cite>
Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, et al. Clinical spectrum and pleiotropic nature of <em>CDH1</em> germline mutations. J Med Genet (2019) 56(4):199–208. doi:  10.1136/jmedgenet-2018-105807
</cite> [<a href="https://doi.org/10.1136/jmedgenet-2018-105807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6581119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30661051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Genet&amp;title=Clinical%20spectrum%20and%20pleiotropic%20nature%20of%20CDH1%20germline%20mutations&amp;author=J%20Figueiredo&amp;author=S%20Melo&amp;author=P%20Carneiro&amp;author=AM%20Moreira&amp;author=MS%20Fernandes&amp;volume=56&amp;issue=4&amp;publication_year=2019&amp;pages=199-208&amp;pmid=30661051&amp;doi=10.1136/jmedgenet-2018-105807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63">
<span class="label">63.</span><cite>
Jongeneel CV, Kotze MJ, Bhaw-Luximon A, Fadlelmola FM, Fakim YJ, Hamdi Y, et al. A view on genomic medicine activities in Africa: implications for policy. Front Genet (2022) 13:769919. doi:  10.3389/fgene.2022.769919
</cite> [<a href="https://doi.org/10.3389/fgene.2022.769919" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9091728/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35571023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Genet&amp;title=A%20view%20on%20genomic%20medicine%20activities%20in%20Africa:%20implications%20for%20policy&amp;author=CV%20Jongeneel&amp;author=MJ%20Kotze&amp;author=A%20Bhaw-Luximon&amp;author=FM%20Fadlelmola&amp;author=YJ%20Fakim&amp;volume=13&amp;publication_year=2022&amp;pages=769919&amp;pmid=35571023&amp;doi=10.3389/fgene.2022.769919&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>Supplementary Figure 1</span><p>Confirmation of the large deletion involving exons 62 and 63 in <em>ATM</em> detected with the Oncomine™ BRCA Expanded panel using next-generation sequencing and confirmed with multiplex ligation-dependent probe amplification. <strong>(A)</strong> Visualization report for the next-generation sequencing data using Ion Reporter™ Genomic Viewer (IRGV). The copy number data representing the various <em>ATM</em> exons are enclosed in the black box. The reduction in copy number for exons 62 and 63 are circled. <strong>(B)</strong> Graphical multiplex ligation-dependent probe amplification presentation confirming the deletion of <em>ATM</em> exons 62 and 63 using GeneMarker® software for SALSA® MLPA® P0190-D1.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Image_1.jpg" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (75.9KB, jpg) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_1.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (682KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_2.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (695.3KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_3.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (697.7KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/9768488/bin/Table_4.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (657.4KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<a href="#SM1" class="usa-link">
<strong>Supplementary Material</strong>
</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Frontiers in Oncology are provided here courtesy of <strong>Frontiers Media SA</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3389/fonc.2022.938561"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/fonc-12-938561.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (996.2 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9768488/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9768488/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9768488%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9768488/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9768488/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9768488/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/36568162/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9768488/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/36568162/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9768488/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9768488/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="v3m1Msalai1pkusHHizmSpGh8A16Kix97dMeykDTr0vJvAXIXhXWpxzXfsqjN32E">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
